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ABSTRACT 
 
THE EFFECTS OF CHRONIC STRESS ON CD8 T CELLS IN HUMAN ADULTS: AN 
EXAMINATION FROM BENCH TO BEDSIDE 
Christina Marie Slota 
Connie Ulrich 
Life is full of stressors that challenge our health; recent evidence suggests that chronic stress 
leads to altered immune outcomes in humans. While the literature illustrates the chronic stress-
induced changes in immune outcomes, there is limited understanding of the impact of a chronic 
stress response on specific immune cell subsets. The primary objective of this dissertation is to 
examine the effect of a stress hormone and the stress of caregiving on immune cell subsets, 
specifically CD8 T cells. To address this objective, we perform an in vitro experiment with isolated 
CD8 T cell subsets (naïve, central memory, effector memory) from human adults and treated 
them with stress-related hormone, norepinephrine (NE). We also perform a cross-sectional 
matched study of CD8 T cell subsets from twenty-one family caregivers of stem cell transplant 
recipients and twenty age- and gender-matched controls at the National Institutes of Health 
Clinical Center. In CD8 T cell subsets, we conducted flow cytometry analysis for 
immunophenotyping, RT-qPCR and a microarray for gene expression changes, and ELISA for 
protein level assessments on the impact of NE. We examined differences using t-tests and gene 
set enrichment analysis (GSEA) for global gene expression analysis of mRNA changes in NE 
treated and untreated CD8 central memory T cells. We were the first to report that memory CD8 
T cells express higher levels of the NE receptor, beta-2 adrenergic receptor, compared to naïve 
cells. We found memory CD8 T cells had an increase in the mRNA levels of pro-inflammatory 
cytokines and chemokines before and after activation and a decrease in proliferation-related 
cytokines after activation. Protein levels were also significantly increased in pro-inflammatory 
cytokines and decreased in proliferation-related cytokines. Individuals with high levels of NE in 
their serum, or were family caregivers, had a pro-inflammatory state before and after antigenic 
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challenge of memory CD8 T cells. These findings suggest chronically stressed individuals may be 
more susceptible to previously encountered antigenic challenges compared to novel challenges. 
Future research should explore the exact mechanisms behind these stress-related changes in 
memory CD8 T cells and the longitudinal consequences on immunity in chronically stressed 
populations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
TABLE OF CONTENTS 
 
ACKNOWLEDGMENT ........................................................................................................... IV 
ABSTRACT ............................................................................................................................... VI 
LIST OF TABLES .................................................................................................................... XI 
LIST OF ILLUSTRATIONS ................................................................................................. XII 
CHAPTER 1 ................................................................................................................................ 1 
Introduction........................................................................................................................................... 1 
Purpose and Organization ................................................................................................................. 2 
Significance .......................................................................................................................................... 4 
Background........................................................................................................................................... 5 
Nervous-immune communication via norepinephrine and its impact on T cell function ................ 6 
Epigenetic regulation of T cell function ................................................................................................. 8 
Family caregiver immune outcomes and hematopoietic stem cell transplant caregivers ........... 10 
Summary ................................................................................................................................................. 13 
Abstract ............................................................................................................................................... 16 
Introduction......................................................................................................................................... 17 
Background......................................................................................................................................... 18 
Method ................................................................................................................................................. 20 
Results ................................................................................................................................................. 21 
Psychological models and epigenetic mediation of stress-induced immune changes ................ 22 
Behavioral models of epigenetic modulation of stress-induced immune changes ....................... 23 
Discussion ............................................................................................................................................... 24 
Table 2. Summary of represented epigenetic studies of psychosocial factors. ............................ 28 
Table 3. Summary of represented epigenetic studies of health behaviors .................................... 29 
Figure 1. Proposed framework of caregiving stress-induced psychosocial and behavioral 
changes with epigenetic modifications as a mediator of biological immune outcomes. .............. 30 
CHAPTER 3 .............................................................................................................................. 31 
ix 
 
Abstract ............................................................................................................................................... 32 
1. Introduction .................................................................................................................................... 34 
2. Materials and Methods .................................................................................................................. 35 
2.1 Human subjects and blood collection ........................................................................................... 35 
2.2 Flow cytometry analysis.................................................................................................................. 36 
2.3 Isolation and culture of human CD8 T cell subsets from adults with NE ................................. 37 
2.4 Gene expression analysis by microarray ..................................................................................... 38 
2.5 Quantitative RT-PCR of mRNA of human donors ...................................................................... 39 
2.6 Measurement of cytokine protein by ELISA ................................................................................ 40 
2.7 Assay for Adrenergic Receptor agonist and antagonists ........................................................... 40 
2.8 NE measurements in serum .......................................................................................................... 41 
2.9 Statistics ............................................................................................................................................ 41 
3. Results ............................................................................................................................................. 41 
3.1 ADRB2 is highly expressed in the memory subsets compared to the naïve subset of CD8 T 
cells .......................................................................................................................................................... 42 
3.2 NE induces expression of inflammatory cytokines and chemokines in memory CD8 cells . 42 
3.3 Activation induces greater expression of inflammatory cytokines and chemokines in NE 
treated memory CD8 cells .................................................................................................................... 43 
3.4 Activation induces lower expression of growth-related genes in NE treated memory CD8 T 
cells and consequently reduces activation-induced expansion of CD8 T cells ............................. 44 
3.5 NE effect on memory CD8 T cells is mediated by ADRB2 ........................................................ 45 
3.6 High blood NE levels are associated with enhanced expression of inflammatory cytokines 
in memory CD8 T cells .......................................................................................................................... 46 
4. Discussion ...................................................................................................................................... 47 
CHAPTER 4 .............................................................................................................................. 81 
Abstract ............................................................................................................................................... 82 
Introduction......................................................................................................................................... 83 
Methods ............................................................................................................................................... 85 
Human subjects and blood collection .................................................................................................. 85 
Flow cytometry for phenotype and intracellular cytokine analyses ................................................. 85 
Isolation and culture of human CD8 T cell subsets ........................................................................... 86 
Quantitative RT-qPCR of mRNA .......................................................................................................... 86 
Statistics .................................................................................................................................................. 87 
Results ................................................................................................................................................. 87 
T lymphocyte composition is similar between controls and HSCT caregivers .............................. 87 
Increased expression and intracellular cytokine proteins of pro-inflammatory cytokines and 
chemokines in caregivers compared to controls ............................................................................... 87 
Discussion .......................................................................................................................................... 88 
CHAPTER 5 .............................................................................................................................. 94 
x 
 
Overview .............................................................................................................................................. 94 
Summary ............................................................................................................................................. 94 
Major Findings .................................................................................................................................... 95 
Epigenetic regulation may serve as a mediator of stress-induced psychological and behavioral 
changes and T cell function .................................................................................................................. 95 
Memory CD8 T cells are more susceptible to norepinephrine than naïve cells ............................ 97 
Individuals with high levels of NE in their serum mimic in vitro results of a pro-inflammatory 
state .......................................................................................................................................................... 98 
Family caregivers of stem cell transplant patients have altered T cell function compared to 
matched controls .................................................................................................................................... 99 
Limitations ........................................................................................................................................ 100 
Future Research ............................................................................................................................... 102 
Histone modifications and T cell alterations in chronically stressed populations ....................... 102 
Mechanisms behind stress induced changes in immune cells ...................................................... 103 
Coping moderates chronic stress-induced alterations in immune outcomes .............................. 104 
BIBLIOGRAPHY .................................................................................................................. 108 
 
 
 
 
 
 
 
 
 
 
 
xi 
 
 
 
LIST OF TABLES 
 
Table 2.1: Definition of epigenetic terminology…………………………………………….....…27 
Table 2.2: Psychosocial studies of epigenetic immune outcomes………………………….…28 
Table 2.3: Behavioral studies of epigenetic immune outcomes…………………………….…29 
Table 3.1: List of donors for the in vitro investigation…………………………………………...64 
Table 3.2: List of donors for the in vivo investigation…………………………………………...67 
Table 3.3: Primer sequences for RT-qPCR……………………………………………………...69 
Table 3.4: List of inflammatory genes from GO database in resting CD8 Tcm cells………..70 
Table 3.5: List of inflammatory genes from GO database in activated CD8Tcm cells…..….74 
Table 4.1: Immune cell composition in family caregivers and non-caregivers………………87 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
LIST OF ILLUSTRATIONS 
 
Figure 2.1: Proposed framework for epigenetic study of family caregivers………….................30 
Figure 3.1: Beta-2 Adrenergic Receptor expression on CD8 T cell subsets……….……………51 
Figure 3.2: NE induced expression of inflammatory cytokines before activation.......................53 
Figure 3.3: NE induced expression of inflammatory cytokines after activation………………....55 
Figure 3.4: Growth related cytokine expression after activation……………………………….....57 
Figure 3.5: NE induced CD8 Tcm changes are mediated by ADRB2…………………………....59 
Figure 3.6: Blood levels of NE in humans related to cytokine expression of CD8 T cells……...62 
Figure 3.7: Gating strategy for ADRB2 staining…………………………………………….……....79 
Figure 3.8: CD8 T cell gene expression and cytokine proteins in caregivers, non-caregivers…80 
Figure 4.1: Immune cell composition of family caregivers and non-caregivers……………….…91 
Figure 4.2: Proinflammatory cytokines increase in family caregivers…………………………….93 
 
1 
 
CHAPTER 1  
 
Introduction 
 
Stress is a common aspect of modern life and can be perceived as a burden when extended over 
long periods of time. The definition of stress used for this dissertation is a constellation of events, 
consisting of a stimulus (stressor) that precipitates a reaction in the brain (perception), which 
activates a physiologic fight-or-flight response by the body (stress response) (Dhabhar, Malarkey, 
Neri, and McEwen, 2012). Stress-induced biological changes in the immune system can include: 
decreased cytokine, lymphocyte and immunoglobulin counts, decreased immune cell proliferation 
and functionality, increased infection rates, impaired responses to vaccines, and dysregulation in 
the inflammatory response (Cohen, Doyle, and Skoner, 1999;Glaser, Kiecolt-Glaser, Malarkey, 
and Sheridan, 1998;Gouin, Hantsoo, and Kiecolt-Glaser, 2008;Kiecolt-Glaser, Glaser, 
Shuttleworth, Dyer, Ogrocki, and Speicher, 1987;Vedhara, Shanks, Anderson, and Lightman, 
2000). These cellular impairments in immune health are the result of a stressful environment that 
puts individuals at risk for infection or physical and psychological illnesses; thus, it is important to 
study the relationship between stress and immune function in greater depth.  
 A growing body of evidence shows the moderating effect of the sympathetic nervous 
system (SNS) on the immune system (Elenkov, Wilder, Chrousos, and Vizi, 2000;Sanders and 
Straub, 2002). Communication between the nervous and immune system is integral to the stress-
induced changes seen in human adults since the SNS releases catecholamines that interact with 
surface receptors on immune cells to modulate their function (Kavelaars, 2002;Khan, Sansoni, 
Silverman, Engleman, and Melmon, 1986;Kin and Sanders, 2006;Rohleder, Marin, Ma, and 
Miller, 2009). Although over 150 clinical trials and animal studies have shown that environmental 
stressors can negatively impact immune function (Murgatroyd, Wu, Bockmuhl, and Spengler, 
2010;Padgett and Glaser, 2003;Romana-Souza, Assis de Brito, Pereira, and Monte-Alto-Costa, 
2014;Zieker, Zieker, Jatzko, Dietzsch, Nieselt, Schmitt, Bertsch, Fassbender, Spanagel, Northoff, 
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and Gebicke-Haerter, 2007), there is a gap in our understanding of how prolonged stress and the 
subsequent nervous-immune communication impacts the function of specific immune cells on the 
molecular, transcriptional, translational, and cellular levels. Specifically, we lack information 
related to: 1) potential molecular mechanisms behind stress-induced changes in immune 
outcomes seen in stressed populations, like family caregivers; 2) the effects of stress hormones, 
like norepinephrine, on human CD8 T cells’ and their subsets’ (naïve, central memory, effector 
memory) function; 3) the effect of chronic psychological stress, like caregiving, on naïve and 
memory CD8 T cells’ function.  Better understanding of how a prolonged stress response can 
influence the CD8 T cells of human adults could provide insight into the changes seen in the 
immune outcomes of chronically stressed populations, including family caregivers.  
 
Purpose and Organization 
 
The purpose of this research is to elucidate the impact of stress on the immune cells of human 
adults and family caregivers by examining changes in CD8 T cell subsets’ transcription and 
translation of cytokines and chemokines, and CD8 T cell function. The primary objective of this 
dissertation is to examine the effect of psychological stress or stress released hormones 
on the function of immune cell subsets, specifically CD8 T cells (naïve and memory).  This 
dissertation is comprised of five chapters and uses the three-article dissertation format. The first 
chapter includes an explanation of the significance of the problem and a comprehensive review of 
the literature that explores the following: nervous-immune communication via norepinephrine and 
its impact on T cell function; the potential role of epigenetics in moderating immune function in 
humans; and the impact of caregiving on immune health outcomes with a focus on family 
caregivers of stem cell transplant recipients.  
 Chapter 2 is the first article in the three article series. It is a theoretical paper exploring 
the literature related to stress-induced lifestyle changes, epigenetic mechanisms (DNA 
methylation and histone modifications) and immune outcomes, and proposes a framework for 
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examining the potential role of epigenetic changes as a mediator between stress-induced 
behavioral and psychological changes, and poor immune function in family caregivers. The 
specific aims of this paper are: 1) to review the existing literature on the relationship 
between stress-induced lifestyle changes, epigenetic mechanisms, and immune function 
in humans; 2) to propose a framework for examining the potential mediating impact of 
epigenetic regulation between stress-induced behavioral and psychological factors, and 
immune function in family caregivers and 3) to lay out potential areas for future research 
and challenges to conducting this type of research. This work merges the caregiving, 
immunology, behavioral and psychological literature to illustrate the potential benefit of 
conducting this type of research. This article will be submitted for publication in Biological 
Research for Nursing in Spring 2015.  
 Chapter 3, the second article of the three-article dissertation, is a primary, data-based 
paper that utilized human blood to conduct an in vitro investigation of the impact of 
norepinephrine on CD8 T cell subsets (naïve, central memory, effector memory) at resting, and 
24 and 72 hours after activation with antibodies for CD3 and CD28. In addition, we used blood 
samples and norepinephrine measured in the serum of human adults to examine the impact of 
high levels of norepinephrine (>150 pg/mL) compared to low levels (<150 pg/mL) of 
norepinephrine on CD8 T cell subsets (naïve and memory). The specific aims of this paper 
are: 1) To examine the expression of norepinephrine’s receptor (beta-2 adrenergic 
receptor) on CD8 T cell subsets (naïve, central and effector memory); 2) To examine the 
impact of norepinephrine exposure on global gene expression changes in central memory 
CD8 T cells; 3) To examine the gene expression changes of cytokines and chemokines in 
CD8 T cell subsets treated with norepinephrine before and after activation; 4) To examine 
the protein level changes in cytokines and chemokines in CD8 T cell subsets and 5) To 
examine changes in identified cytokines and chemokines altered with norepinephrine 
treatment in individuals with high levels of norepinephrine compared to the low level 
group. In this paper, we examine the effect of norepinephrine in CD8 T cell subsets in vitro, as 
4 
 
well as in vivo with human adults to understand if norepinephrine has a similar or different impact 
on the three major CD8 T cell subsets. This article was submitted for publication to Brain 
Behavior Immunity in Fall 2014 and received reviewer comments to revise and resubmit.  
 Chapter 4, the third article of the three-manuscript dissertation, is also a primary-data 
based study and uses a cross-sectional design of family caregivers of hematopoietic stem cell 
transplant recipients and their age-, gender- and ethnicity-matched non-caregiver controls to 
examine the impact of caregiving stress on cytokine and chemokine gene expression, and protein 
levels in CD8 T cell subsets (naïve and memory). The specific aims are: 1) To examine the 
effect of caregiving on leukocyte composition compared to non-caregivers; 2) To examine 
the effect of caregiving on intracellular cytokine production of CD8 T cells compared to 
non-caregivers by flow cytometry analysis; and 3) To examine gene expression changes in 
inflammation-related cytokines and chemokines in caregivers compared to controls. In this 
paper we explore the differences in immune cell composition and CD8 T cell expression of 
important cytokines and chemokines in family caregivers of stem cell transplant recipients 
compared to their matched controls. This article will be submitted for publication in 
Psychosomatic Medicine by Spring 2015.  
 Chapter 5 is the final chapter of this dissertation and presents a discussion of findings 
from all three manuscripts (one theoretical and two data-based papers), and the implications of 
these findings for understanding how stress influences subsets of immune cells differently, and 
recommendations for future research on this important area of research.  
Significance 
 
Previous literature demonstrates conflicting reports in immune cells after exposure to an 
environmental stressor including whether stress is immune-enhancing, immune-suppressive, or 
has no significant impact; a majority of these studies examined changes in whole blood or 
peripheral mononuclear cells (PBMC) (Gouin et al., 2008;Hu, Wan, Chen, Caudle, LeSage, Li, 
5 
 
and Yin, 2014;Kiecolt-Glaser, Glaser, Gravenstein, Malarkey, and Sheridan, 1996;Torres, 
Antonelli, Souza, Teixeira, Dutra, and Gollob, 2005;Vedhara, McDermott, Evans, Treanor, 
Plummer, Tallon, Cruttenden, and Schifitto, 2002;Zieker et al., 2007). Studies on the SNS-
released hormones and neurotransmitters have also reported a contradictory impact on immune 
cells (Elenkov et al., 2000;Kin et al., 2006;Rohleder et al., 2009;Sanders, Baker, Ramer-Quinn, 
Kasprowicz, Fuchs, and Street, 1997;Straub, Schaller, Miller, von, Jessop, Falk, and 
Scholmerich, 2000). In addition, several studies have examined epigenetic regulation and its role 
in mediating immune function, or its relationship to psychological and behavioral-induced 
changes, but not in relation to each other.  
 This dissertation contributes to the field of nursing by providing exploratory insight into 
understanding caregiving as a stressor and how it impacts specific immune cells; in addition, we 
take a first step in understanding the potential link between epigenetic regulation, psychological 
and behavioral factors in caregiving, and immune alterations in family caregivers. We also reveal 
the susceptibility of memory CD8 T cells to norepinephrine (an important hormone released 
during the stress response) exposure, as well as pro-inflammatory and proliferation-related 
cytokines and chemokines altered by norepinephrine treatment. This information will lead to a 
better understanding of how chronic stress, including norepinephrine exposure, can influence 
specific immune cell subsets in a heterogeneous manner. The direct benefits of this study include 
identifying immune cell subsets most susceptible to the effects of caregiving stress or stress 
hormones (norepinephrine), which subsequently leads to the production of a pro-inflammatory 
state. This will help identify individuals at risk for weakened immunological memory responses 
and in the long-term provide future guidance on interventions aimed at stress-reduction in family 
caregivers.  
 
Background 
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In this section, I present an overview of background information related to: nervous-
immune communication via norepinephrine and its previously reported impact on T cell function; 
the role of epigenetic regulation on impacting immune function; and finally a review of family 
caregiver immune outcomes with a specific focus on hematopoietic stem cell transplant family 
caregivers.  
Nervous-immune communication via norepinephrine and its impact on T cell function 
 
T cells are critical to the adaptive immune response as they are major effectors of cell-
mediated responses. There are several subsets of T cells including CD4, CD8 and natural killer T 
cells; each has their own subsets including naïve and memory; for this dissertation, we focus on 
CD8 T cell subsets (naïve, central memory and effector memory). T cell function is mediated by 
the nervous system by the binding of hormones and/or neurotransmitters released by the nervous 
system to interact with surface receptors on T cells, such as adrenergic receptors. This nervous-
immune relationship is of great importance during a stress response, when the somatic effects of 
stress are mediated by the neuroendocrine system. Two major neuroendocrine systems include 
the sympathetic nervous system (SNS) and hypothalamic pituitary adrenal (HPA) axis. The SNS 
releases catecholamines while the HPA axis releases glucocorticoids; immune cells have 
receptors for both catecholamines and glucocorticoids. Catecholamines tend to elicit a pro-
inflammatory response, while glucocorticoids elicit an anti-inflammatory effect on immune cells 
(Chambers, Cohen, and Perlman, 1993;Sperner-Unterweger, Kohl, and Fuchs, 2014).  
While the SNS can release several hormones and neurotransmitters during a stress 
response, its primary catecholamine is norepinephrine (NE), which binds to T cells by the beta-2 
adrenergic receptor. The SNS and NE, in particular, have been associated with the “fight or flight” 
response and contribute significantly to immune function (Kohm and Sanders, 2001). NE is 
produced by chromaffin cells, and released from the sympathetic nerve terminals located in 
lymphoid tissues, and also from the adrenal gland into the blood stream which influences T cells 
both in lymphoid organs and in the periphery (Kohm and Sanders, 2000;Sanders et al., 2002). 
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This interaction is important during a stress response since the SNS and its release of NE and 
stimulation of the beta-2 adrenergic receptor can regulate the magnitude and intensity of an 
immune response (Sanders et al., 2002). Activation of the SNS and subsequent release of 
catecholamines, including NE, have been shown to affect the health of humans in several ways, 
including: contributing to the development of pro-inflammatory diseases, the effectiveness of 
vaccination protocols by altering immunological memory and alterations in immune status of 
depressed individuals (Castle, Wilkins, Heck, Tanzy, and Fahey, 1995;Elenkov et al., 
2000;Glaser et al., 1998;Gouin et al., 2008;Mills, Adler, Dimsdale, Perez, Ziegler, Ancoli-Israel, 
Patterson, and Grant, 2004). Binding of NE and activation of the beta-2 adrenergic receptor leads 
to the release of certain cytokines from T cells, which creates a feedback loop to the SNS and 
brain; this bidirectional communication between the nervous system and the immune system has 
significant influence on immune function, particularly during chronic stress experiences (Kohm et 
al., 2001). Since the majority of our stress today is psychological and chronic, we need to learn 
more about the interaction between the SNS and immune system, and the impact of prolonged 
exposure of immune cells to stress hormones, like norepinephrine.  
The majority of studies examining the effects of NE on T cells have been conducted in 
NK or CD4 T cells. These studies have found that NE can elicit a transient increase in NK number 
and activity and a decrease in CD4 activity and proliferation (Khan et al., 1986;Sanders, 
Kasprowicz, Swanson-Mungerson, Podojil, and Kohm, 2003). The Th2 subset of CD4 cells are 
unaffected by NE since they lack the beta-2 adrenergic receptor on their cell surface, unlike their 
Th1 and naïve counterparts; as for other T cells, the number of receptors differs depend on the 
cell type, with CD8 T cells having more receptors than CD4 T cells (Ramer-Quinn, Baker, and 
Sanders, 1997;Sanders, 2012;Sanders et al., 2003); yet, it is unknown about the expression of 
beta-2 adrenergic receptor on CD8 T cell subsets. NE and beta-2 adrenergic receptor stimulation 
also significantly influence the cytokine production of T cells, though this has primarily been 
studied in CD4 T cells (Kohm et al., 2001). Many of these studies show conflicting findings; some 
report increased production of IL1-α, IL-6, IL-10 and IFN-γ, while others show a decrease in these 
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cytokines (Elenkov et al., 2000;Swanson, Lee, and Sanders, 2001;Van Tits, Michel, Grosse-
Wilde, Happel, Eigler, Soliman, and Brodde, 1990). The inconsistency in findings suggests 
stimulation of the beta-2 adrenergic receptor by NE may be regulated by additional factors, such 
as cell subset.  
Epigenetic regulation of T cell function 
 
 Epigenetics serve as one molecular mechanism that can influence the expression of 
immune-related genes through environmental factors, including modifications in gene expression 
without altering the DNA sequence (Allis, Jenuwein, and Reinberg, 2013). Broadly speaking, 
epigenetics is the study of how the environment impacts gene activity without alterations in DNA. 
The epigenome acts as a gatekeeper of gene expression determining when to turn genes ‘on’ or 
‘off,’ impacting transcription of genes. These epigenetic alterations can be long-term and 
heritable, resulting in disease development (Santos-Reboucas and Pimentel, 2007). Initially, DNA 
is tightly wound into coils around proteins called histones (H2a, H2b, H3, and H4 in octomers). 
This coiled combination of a histone plus DNA is called chromatin (colloquially pictured as beads 
on a string), and these chromatin structures are then coiled into chromosomes (Allis et al., 2013).  
Epigenetic marks regulate when and where these coils are unraveled, determining which genes 
can be expressed. For example, if a piece of DNA is wound tightly around a histone, the 
transcription machinery cannot bind to the DNA and express the gene (i.e. transcribe the gene 
into mRNA and then into protein). It is therefore necessary to open up the coil of DNA on the 
histone to access the desired gene. There are many types of epigenetic modifications; a 
frequently studied epigenetic mechanism includes acetylation of the N-terminal of the histone.  
Acetylation of the histone tail at specific sites causes the shape of the histone to change and 
allows for the unraveling of the DNA exposing certain genes at the unraveled spot to be 
transformed into proteins.  
 Recent studies have discovered that one form of epigenetic changes, histone 
modifications, are critical for proper activation and functioning of the immune system, including T 
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cells (Araki, Fann, Wersto, and Weng, 2008;Araki, Wang, Zang, Wood, III, Schones, Cui, Roh, 
Lhotsky, Wersto, Peng, Becker, Zhao, and Weng, 2009;Avni, Lee, Macian, Szabo, Glimcher, and 
Rao, 2002;Chang and Aune, 2007). Epigenetic regulation via DNA methylation and/or histone 
modifications are critical for proper T cell development, differentiation and function during a 
healthy human immune response and in an aged immune response (Araki et al., 2009;Fann, 
Godlove, Catalfamo, Wood, III, Chrest, Chun, Granger, Wersto, Madara, Becker, Henkart, and 
Weng, 2006;Fitzpatrick and Wilson, 2003). These epigenetic alterations are important to allow for 
immune response genes to be activated during an antigenic challenge. Emerging evidence 
suggests that epigenetic alterations at the chromatin level play an important role in controlling the 
distinct transcriptional profiles of memory T cells and their subsequent ability to function (Weng, 
Araki, and Subedi, 2012). A genome-wide analysis of histone methylation on two histone lysine 
sites (H3K4me3 and H3K27me3) and gene expression profiles of naïve and memory CD8+ T 
cells found that a positive correlation exists between gene expression and the amount of H3K4 
methylation, and a negative correlation exists between gene expression and H3K27 methylation 
(Araki et al., 2009). In summary, this study concluded transcription is highly controlled at the 
chromatin level and specifically relevant to the function of memory CD8+ T cells. These findings 
also suggest that histone modifications impact the function of memory CD8+ T cells, and different 
epigenetic mechanisms (e.g. methylation, acetylation) impact transcriptional capability and thus 
functionality of naïve and memory CD8+ T cells. For immune function, this means that histone 
modifications impact the ability of memory CD8+ T cells to recognize antigens and mount a rapid, 
strong cellular response. Another study found T helper cell differentiation is associated with 
histone acetylation and chromatin remodeling for the genes encoded for IL4 and IFNG (Avni et 
al., 2002). This means that histone acetylation may be a major mechanism of controlling cytokine 
genes and thus transcription of cytokines in naïve and helper T cells. On a broader level, if 
inappropriate cytokine genes are repressed by this epigenetic mechanism (histone acetylation), 
then it will reflect poorly on overall immune function. One study showed that histone methylation 
is highly dynamic for the locus encoding IFN-G, an important cytokine for T cell functioning and 
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proliferation (Chang et al., 2007). While many studies focus on epigenetic changes in early life on 
immune cells (King, Ismail, Davis, and Karp, 2006;Murgatroyd, Patchev, Wu, Micale, Bockmuhl, 
Fischer, Holsboer, Wotjak, Almeida, and Spengler, 2009;Murgatroyd and Spengler, 
2011;Murgatroyd et al., 2010), it is important to examine later life changes in adulthood to 
understand mechanisms behind immune function changes in the aging.  
Family caregiver immune outcomes and hematopoietic stem cell transplant caregivers 
 
 This section reviews the literature pertaining to immunological outcomes in the family 
caregiver population with a specific focus on T cells, as well as a background on hematopoietic 
stem cell transplant (HSCT) family caregivers.  
 A large body of literature has identified an association between caregivers and altered 
immunological outcomes (i.e. natural killer (NK) cell cytotoxicity, T cell function, vaccination titers 
and cytokine production). While numerous cell types have been examined, here we will focus on 
the influence of caregiving on lymphocytes. Studies have shown that the chronic psychological 
stress of caregiving leads to significantly lower percentage of T cells overall, but higher 
percentages of CD8 T cells and lower percentages of suppressor and helper T cells (Pariante, 
Carpiniello, Orru, Sitzia, Piras, Farci, Del Giacco, Piludu, and Miller, 1997;Vitaliano, Scanlan, 
Ochs, Syrjala, Siegler, and Snyder, 1998). Alterations in the composition of immune cells in the 
periphery can negatively impact the immune system; for example, fewer helper T cells may mean 
the immune system has a lower capacity to activate cytotoxic T cells, while a higher percentage 
of these cells may be useless if they are not able to be notified by the helper T cells or turned off 
by suppressor T cells. Additional results showed caregivers who reported higher levels of 
psychological stress correlated positively with T regs and T cytotoxic cells, and correlated 
negatively with T helper/suppressor ratio (Pariante et al., 1997), suggesting the severity of 
perceived psychological stress moderates the influence of stress on immune changes. 
Investigations into immune alterations in family caregivers of Alzheimer’s patients found a 
cytokine shift from CD4 Th1 subtype to CD4 Th2 as well as an increase in pro-inflammatory 
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cytokines like TNF and a decrease in proliferation related cytokines like IL-2 and IFN-γ (Glaser et 
al., 1998;Kiecolt-Glaser et al., 1996;Kiecolt-Glaser et al., 1987). Studies on caregivers of patients 
with other forms of dementia found caregivers who reported high stress had reduced T cell 
proliferation and an increase in the percentage of CD8 T cells (Castle et al., 1995). Several 
studies found caregivers of cancer patients and dementia patients had an increase in pro-
inflammatory cytokines, slower wound healing, and poorer response to vaccination (Glaser et al., 
1998;Kiecolt-Glaser et al., 1996;Kiecolt-Glaser et al., 1987;Kiecolt-Glaser, Marucha, Malarkey, 
Mercado, and Glaser, 1995;Kiecolt-Glaser, Preacher, MacCallum, Atkinson, Malarkey, and 
Glaser, 2003).  
 Clearly, the literature demonstrates that caregivers of the elderly, those with Alzheimer’s 
disease or cancer patients have numerous altered immunological outcomes. Yet, other caregiver 
populations like HSCT caregivers are not as well understood in terms of immunological changes 
due to caregiving stress. According to a study by Gratwohl and colleagues, the use of HSCT has 
rapidly expanded and as of 2006, over 50,417 HSCTs were reported worldwide, including 21,516 
allogeneic transplants (Gratwohl, Baldomero, Aljurf, Pasquini, Bouzas, Yoshimi, Szer, Lipton, 
Schwendener, Gratwohl, Frauendorfer, Niederwieser, Horowitz, and Kodera, 2010). HSCT 
caregivers endure what is arguably one of the most intense treatments available for cancer 
patients which can result in physical, psychological and social challenges (Beattie and Lebel, 
2011). In addition, the need to decrease inpatient healthcare costs has motivated the move of 
HSCT and recovery to outpatient settings, requiring caregivers to assume care that would 
otherwise be provided in a supervised medical setting (Rizzo, Vogelsang, Krumm, Frink, Mock, 
and Bass, 1999).  
In order to understand how allogeneic HSCT caregiver is an ideal subject to evaluate 
chronic stress of caregiving, it is important to understand the transplantation process itself. 
Allogeneic HSCT is when hematopoietic stem cells from a histologically compatible relative or 
unrelated donor are collected either from peripheral blood while an autologous HSCT is when the 
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patient’s own cells are harvested, stored, and then re-infused during transplant (Shelburne and 
Bevans, 2009). Despite the growth in transplantations and responsibilities caregivers assume 
during the intense HSCT transplant and post-transplantation process, there is limited research on 
the family caregivers of HSCT recipients. The two major types of allogeneic HSCT include: 
standard treatment which includes chemotherapy and/or radiation given before transplantation 
and 2) reduced intensity conditioning which is less intense and given to adults over the age of 55 
to improve survival (Shelburne et al., 2009). While the HSCT transplantation process itself can be 
stressful, it is the recovery period that presents a significant challenge to family caregivers due to 
the serious and sometimes life-threatening toxicities that can arise from any of the following: 
chemo- and radio-therapy; graft versus host disease, or medication side-effects from 
immunosuppression (Bevans, Wehrlen, Prachenko, Soeken, Zabora, and Wallen, 2011). Even 
under the best conditions, HSCT caregivers experience significant chronic stress in their role; 
HSCT typically requires a month hospital stay with three to four months of intense outpatient 
care. During this time, family caregivers face a variety of stressors that may negatively impact 
their health. For example, during the pre-transplantation timeframe caregivers must coordinate 
transportation to the clinic, find new long-term housing near the clinic, and potentially face 
emotional distress from the uncertainty of the effectiveness of the transplantation; pre-
transplantation has been reported as the most stressful time for caregivers (Bevans et al., 2011). 
After transplantation, family caregivers are the main care providers of the transplant recipients; 
they complete everyday tasks like preparing meals, bathing, and house cleaning, to medical tasks 
of assessing their care-recipient for potential medical complications and declines in health. With 
the significant time and attention dedicated to the transplant recipient, HSCT caregivers have little 
time or energy left to focus on their own emotional, behavioral, and physical health. In 2006, an 
alarming report found 53% of family caregivers of mixed patient populations reported a decline in 
their health, affecting their ability to provide care (National Alliance for Caregiving, 2009).  
The majority of literature on transplant caregivers examines the effects of caregiving on 
psychosocial and emotional health outcomes (Beattie et al., 2011;Bevans et al., 2011;Frey, 
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Stinson, Siston, Knight, Ferdman, Traynor, O'Gara, Rademaker, Bennett, and Winter, 
2002;Northouse, Williams, Given, and McCorkle, 2012;Shelburne et al., 2009;Siston, List, 
Daugherty, Banik, Menke, Cornetta, and Larson, 2001). Two studies reported high perceived 
stress in HSCT caregivers, but made no correlations between high reported stress and changes 
in immune function (Beattie et al., 2011;Northouse et al., 2012). There is little knowledge on the 
immune outcomes of this population of caregivers. One study by Futterman et al. (1996), 
examined the impact of bone marrow transplantation on caregivers’ immunological status and 
found there was a significant negative correlation between caregivers’ reported stress and the 
total percentage of T cells and CD4+ T cells (Futterman, Wellisch, Zighelboim, Luna-Raines, and 
Weiner, 1996). The immune function of HSCT caregivers requires further investigation; we were 
able to address this topic since we had access to blood samples from this particular group of 
caregivers. Understanding of HSCT caregiver immunity can aid in illustrating further the immune 
health outcomes of caregivers, particularly in a population that is chronically stressed and may 
undergo an event that can serve as an acute stressor.  
Summary 
 
This dissertation is a preliminary, exploratory step in filling knowledge gaps in how CD8 T 
cell subsets (naïve and memory) are influenced by norepinephrine and caregiving stress. This 
work explores functional changes of CD8 T cells in vitro and in vivo by studying isolated CD8 T 
cell subsets in culture with the catecholamine released during stress, norepinephrine, and in vivo 
by examining a chronically stressed population: family caregivers of stem cell transplant 
recipients. The knowledge generated from this project will include identification of areas for 
further research, potential obstacles that may be encountered in this field, and promising areas 
for examining the effects of stress on immunological function, particularly on immunological 
memory. Chapter 2 explores the recent literature surrounding epigenetics as a potential 
mechanism behind stress-induced changes in the immune system, and offers a proposed 
framework for study in family caregivers, as well as potential obstacles encountered in this area 
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of research. Chapter 3 and 4 consist of two primary data-based papers based on an in vitro and 
in vivo study on the function of CD8 T cell subsets in humans altered by norepinephrine or 
caregiving. This research explores the impact of stress on important cells to the adaptive immune 
response (CD8 T cells) in humans with a translational approach from bench (in vitro) to bedside 
(in vivo). 
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Abstract  
 
Introduction: Research has demonstrated a link between poor immune outcomes and the stress 
of family caregivers; however, there is a gap in the understanding of potential molecular 
mechanisms underlying the link between caregiving stress and immune dysfunction. Aims: To 
review the literature on how epigenetic changes may serve as a mediator between stress-induced 
psychological and behavioral changes, and T cell function in family caregivers. Methods: The 
review was conducted by a search of published studies in electronic databases. Results: Nine 
articles met our review criteria. The reviewed literature clearly illustrated a relationship between 
stress-induced psychosocial and behavioral changes, epigenetic mechanisms (DNA methylation 
and histone modifications), and altered T cell function in humans. No literature discussed the 
potential role of epigenetics in mediating stress-induced changes in family caregivers’ immune 
outcomes. Conclusion: We identify the technical, methodological and practical challenges of 
conducting epigenetic studies on humans, including family caregivers. Despite these challenges, 
identification of epigenetic mechanisms mediating stress-induced changes in T cell function of 
family caregivers could assist in the development of targeted stress-reduction interventions. 
Finally, we propose a framework in which epigenetic regulation may serve as a mediator between 
stress-induced psychological and behavioral factors, and altered immune function in the family 
caregiver population.  
 
Keywords: epigenetics, family caregivers, stress, immune health, literature review 
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Introduction 
 
Previous evidence has shown the negative impact of chronic stress on health, particularly 
related to immune health outcomes (Bonneau, Kiecolt-Glaser, and Glaser, 1990;Kemeny and 
Schedlowski, 2007;Kiecolt-Glaser et al., 1996;Kiecolt-Glaser et al., 1987;Kiecolt-Glaser et al., 
1995;Pariante et al., 1997). Much of this research has been conducted in family caregivers since 
they are an ideal population to study the effects of chronic stress; caregivers are generally 
stressed for extended periods of time, and suffer worse health outcomes and increased mortality 
and morbidity compared to non-caregivers (Rohleder et al., 2009;Schulz and Beach, 1999). 
Although the detrimental effect of stress on immune function has been reported extensively in 
family caregivers, there is less understanding of the mechanisms underlying stress induced 
changes in immunity, such as neuroendocrine mechanisms or molecular mediators (Segerstrom 
and Miller, 2004).   
 Epigenetics is one molecular mechanism that controls the expression of genes without 
altering the DNA sequence (Allis et al., 2013). The field of epigenetics holds promise for 
elucidating how lifestyle factors, like a stressful environment, can influence the expression of 
immune-related genes. Emerging evidence suggests epigenetic regulation may serve as a 
potential mediator of stress-induced psychosocial and behavioral changes, and alterations in 
immune function (Mathews and Janusek, 2011;Mathews, Konley, Kosik, Krukowski, Eddy, 
Albuquerque, and Janusek, 2011;Mifsud, Gutierrez-Mecinas, Trollope, Collins, Saunderson, and 
Reul, 2011).  Several excellent reviews have discussed the connection between stress-
induced lifestyle changes and epigenetic modifications, particularly on stress-induced 
psychosocial and behavioral alterations which impact the epigenome (Alegria-Torres, Baccarelli, 
and Bollati, 2011;Mathews et al., 2011;McEwen, 2012). Reviews have also been conducted on 
epigenetic regulation of immune cell genes, including T cells (Kondilis-Mangum and Wade, 
2013;Lim, Li, Holloway, and Rao, 2013;Reiner, 2005;Weng et al., 2012).  
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Despite these findings, a review of the potential relationship between chronic-stress 
induced psychosocial and behavioral changes, epigenetic regulation, and immune alterations has 
not been completed. Several lifestyle factors such as diet, physical activity, smoking, alcohol use, 
and stress have been identified to potentially modify epigenetic patterns (Alegria-Torres et al., 
2011;Lee, Sahoo, and Im, 2009). While the lifestyle factors and immune outcomes of family 
caregivers have been examined previously, no work has yet examined the potential role of 
epigenetic changes mediating caregiving stress-induced immune dysfunction.  
The purpose of this review is to explore how epigenetic changes may serve as a 
mediator between stress-induced behavioral and psychological changes, and poor immune 
function in family caregivers. Here, we review the literature on human studies of behavioral and 
psychological changes common to family caregivers and their connection to epigenetic changes 
(DNA methylation and histone modifications) in T cells. We focus on T cells since they are critical 
players in the adaptive immune response and have been previously shown to be partly regulated 
by epigenetic mechanisms (Lee et al., 2009; Bowen, Kelly, Lee, & Lavender, 2008; Weng et al., 
2012; Sanders, 2006; Bandyopadhyay, Montagna, & Macian, 2012). Table 1 provides definitions 
for epigenetic-related terms cited in this review. We identify the technical, methodological and 
practical challenges of conducting human epigenetic studies, particularly in family caregivers. 
Finally, a proposed framework is presented in which epigenetic regulation serves as a mediator 
between stress-induced psychological and behavioral factors, and biological immune responses 
in the family caregiver population.  
Background 
 
Epigenetic mechanisms, including DNA methylation, and histone methylation and 
acetylation, play a role in altering the function of T cells by changing the gene expression of 
cytokines and chemokines important to T cells, and thus impacting the quality of the adaptive 
immune response. Previous reviews have extensively covered the various types of epigenetic 
modifications that impact the gene expression of T cells (Kondilis-Mangum et al., 
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2013;Kouzarides, 2007;Lim et al., 2013;Mathews et al., 2011;Mifsud et al., 2011), however this 
review will focus on DNA methylation, and histone methylation and acetylation since these 
epigenetic marks tend to be heritable and long-term (Greer and Shi, 2012). 
DNA methylation is one form of a covalent modification and involves the addition of a 
methyl group onto cytosines at CpG dinucleotides which have significant influence over 
transcription (Lee et al., 2009). Little to no methylation of the CpG islands is typically associated 
with genes that are actively transcribed, compared to methylation of the CpG islands that are 
associated with gene silencing (Weng et al., 2012). Methylation can also occur at interspersed 
repetitive sequences, including long interspersed nuclear elements (LINEs) and Alu (Sukapan, 
Promnarate, Avihingsanon, Mutirangura, and Hirankarn, 2014). LINE-1 and Alu are considered 
representative of genome-wide methylation marks and considered as proxies for global DNA 
methylation status in T lymphocytes (Kitkumthorn and Mutirangura, 2011;Nakkuntod, 
Avihingsanon, Mutirangura, and Hirankarn, 2011;Sukapan et al., 2014).  
While DNA methylation is involved in the repression of transcription, post-translational 
histone modifications can activate or repress transcription depending on the position and type of 
modification (Johnson and Dent, 2013;Northrup and Zhao, 2011). Histones are the basic 
components where the DNA wraps around two copies of the four core histones (H2A, H2B, H3 
and H4) to form nucleosomes or ‘beads on a string’ that together form chromatin (Lee et al., 
2009). The methylation or acetylation of histones are two forms of posttranslational histone 
modifications that can define the chromatin structure and transcriptional capacity of a gene; H3 
and H4 being the most commonly methylated or acetylated on lysine (K) residues (Lee et al., 
2009). Acetylation involves the addition of an acetyl group (COCH3) to lysine (K) residues and is 
regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs) (Gong and 
Miller, 2013); histone acetylation is related to activation of transcription, while histone 
deacetylation is associated with repression of transcription (Falvo, Jasenosky, Kruidenier, and 
Goldfeld, 2013).  
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The biological function of T cells, including the release of cytokines and chemokines has been 
extensively studied for many years; however the molecular mechanisms, including chromatin 
remodeling, is in its infancy (Lee et al., 2009;Reiner, 2005). The cytokine environment and 
interaction with other immune cells, such as CD4 T cells can induce epigenetic modifications in 
CD8 T cell subsets (naïve and memory). For example, CD4 T cells influence the epigenetic 
remodeling of the IL2 and IFNG loci in activated memory CD8 T cells (Northrop, Thomas, Wells, 
and Shen, 2006). IL2, IFNG, and IL4 have been studied extensively in both CD4 and CD8 T cells 
for expression changes controlled by epigenetic mechanisms (Fitzpatrick et al., 2003). Histone 
methylation and acetylation also influences the chromatin states of many important genes, 
including cytokines, that are characteristic of CD4 memory T cells (Weng et al., 2012). In CD8 
memory T cells, genes associated with effector function, including IFN-G, have high levels of 
H3K4me3, but low levels of H3K427me3 (Weng et al., 2012). In addition, studies on T cell 
subsets have focused on the potential of epigenetic regulation of important functional genes 
(Singh, de Camargo, Zhang, Foley, Hedrick, and Farber, 2010;Yano, Ghosh, Kusaba, Buchholz, 
and Longo, 2003).  
Method 
 
We utilized an integrative literature review approach to provide a new framework on the 
topic of stress-induced changes in immune function in family caregivers. The integrative literature 
review was completed on a search of electronic databases including PubMed, Medline, CINAHL, 
Ovid and Cochrane Review with no date limit since there was limited information available. 
Search terms used were: “stress” or “stress response” or “chronic stress”; “family caregivers” or 
“caregiving”; “perceived stress”; “health behaviors” or “health practices”; “psychological pathways” 
or “psychosocial”; “epigenetics”; “immune function” or “immunity” or “T cells,” in various 
combinations. References of identified articles were also searched for additional relevant articles. 
Articles were selected if they met three criteria: a) discussed stress-induced psychosocial or 
behavioral changes that could also be found in the family caregiver population, including: distress 
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(Goossens, Van, Knoppert-van Der Klein EA, and Van, 2008;Khoo, Chen, Ang, and Yap, 
2013;Mourik, Rosso, Niermeijer, Duivenvoorden, Van Swieten, and Tibben, 2004;Pellegrino, 
Formica, Portarena, Mariotti, Grenga, Del, and Roselli, 2010), sleep disturbances , PTSD 
(Jacobson, 2010;Perreira and Ornelas, 2013;Stukas, Jr., Dew, Switzer, DiMartini, Kormos, and 
Griffith, 1999;Teixeira and Pereira, 2014), diet (Abu-Farha, Tiss, Abubaker, Khadir, Al-Ghimlas, 
Al-Khairi, Baturcam, Cherian, Elkum, Hammad, John, Kavalakatt, Warsame, Behbehani, 
Dermime, and Dehbi, 2013;McGuire, Bouldin, Andresen, and Anderson, 2010;Ronn, Volkov, 
Davegardh, Dayeh, Hall, Olsson, Nilsson, Tornberg, Dekker, Eriksson, Jones, Groop, and Ling, 
2013;Zhang, Cardarelli, Carroll, Zhang, Fulda, Gonzalez, Vishwanatha, Morabia, and Santella, 
2011), physical exercise (von, Mausbach, Dimsdale, Mills, Patterson, Ancoli-Israel, Ziegler, 
Roepke, Harmell, Allison, and Grant, 2011;Zhang et al., 2011), or alcohol/smoking use (Alegria-
Torres et al., 2011;Lazarus, 1974;McGuire et al., 2010;Trunzo, Pinto, and Chougule, 2014); b) 
discussed behavioral or psychological pathways related to DNA methylation, or histone 
methylation or acetylation, and c) discussed epigenetic regulation of transcription in T cells or 
their related cytokines. This review excluded unpublished studies, commentaries, and studies not 
conducted in humans.  
Results 
   
Notably, the majority of epigenetic studies on psychological or behavioral induced 
changes in T cells focus on the neuroendocrine system, early life or pregnancy, and have been 
conducted in mouse and rat models (Champagne and Curley, 2009;Hunter, 2012;Jensen, Monk, 
and Champagne, 2012;Murgatroyd, 2014;Murgatroyd et al., 2011;Murgatroyd and Spengler, 
2014;Murgatroyd et al., 2010); there are excellent reviews on these systems (Mathews et al., 
2011;Mifsud et al., 2011). Here, we review human studies (N=9) on psychosocial (n=4) (Table 2) 
and behavioral (n=5) changes (Table 3), and T cell and related cytokines changes via epigenetic 
modifications relevant to the family caregiver population.  
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Psychological models and epigenetic mediation of stress-induced immune changes 
 
Post-traumatic stress disorder (PTSD) develops from a maladaptive stress response 
resulting in poor health outcomes (Yehuda and LeDoux, 2007), yet the molecular mechanisms of 
PTSD are partially unknown. Previous microarrays from PTSD individuals have illustrated 
differential gene expression compared to non-PTSD sufferers (Segman, Shefi, Goltser-Dubner, 
Friedman, Kaminski, and Shalev, 2005;Zieker et al., 2007) suggesting subsequent 
pathophysiology of PTSD. Since alterations in immune function are a feature of PTSD (Segman 
et al., 2005;Zieker et al., 2007), one study examined the role of methylation in distinct-immune 
related gene expression patterns (Uddin, Aiello, Wildman, Koenen, Pawelec, de los, Goldmann, 
and Galea, 2010). This study found uniquely unmethylated genes that were related to immune 
function, especially inflammatory cytokine genes produced by T lymphocytes, and innate 
immunity genes in PTSD individuals compared to controls. The affected genes were significantly 
negatively correlated with traumatic exposure and were also associated with differences in the 
ability to mount an immune response to cytomegalovirus. DNA methylation patterns correlated 
with immune dysregulation in a PTSD study focused on traumatized African American adults from 
Atlanta (Smith, Conneely, Kilaru, Mercer, Weiss, Bradley, Tang, Gillespie, Cubells, and Ressler, 
2011). Global methylation was increased in PTSD individuals and several genes associated with 
inflammation were methylated in individuals with high levels of total life stress; furthermore, T 
lymphocyte cytokine levels of TNF, IL4, and IL2 were associated with PTSD (Smith et al., 2011). 
Another study of methylation patterns in PTSD U.S. military service members found significant 
increase in T lymphocyte produced IL18 promoter region methylation and protein levels in PTSD 
subjects compared to controls (Rusiecki, Byrne, Galdzicki, Srikantan, Chen, Poulin, Yan, and 
Baccarelli, 2013).  
Distress related to poor health can impact immune function via epigenetic changes. 
Mathews and colleagues examined the effects of psychosocial distress on immune function in 
women (n=33) with a new breast cancer diagnosis at the time of diagnosis and four months later 
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after completion of treatment (Mathews et al., 2011). Mathews made a similar case as Uddin for 
the connection between distress and its negative impact on immune health, and both populations 
reported alterations in immune function in their stressed populations of women with a new breast 
cancer diagnosis and PTSD affected individuals, respectively. A correlation was found between 
the perceived stress survey and immune outcomes at the first time point in this study. In 
association with H4K8 acetylation of CD56 lymphocytes, individuals with higher levels of 
perceived stress had lower levels of CD56 lymphocytes as measured by mean fluorescent index 
(MFI). Furthermore, immune dysregulation was associated with a decrease in acetylation of H4K8 
and H4K12. When the stress was reduced at the second time point, immune function was 
improved and no correlations among the variables were significant.  
Behavioral models of epigenetic modulation of stress-induced immune changes 
 
The role of nutrition and exercise in modifying epigenetic mechanisms has been 
examined in multiple studies since epigenetic changes are potentially reversible, and modifiable 
factors such as diet and exercise provide hope for healthy intervention strategies to buffer the 
effects of stress (Abu-Farha et al., 2013;McGee, Fairlie, Garnham, and Hargreaves, 2009;Ronn 
et al., 2013;Zhang et al., 2011). In a human study on postmenopausal women, DNA 
hypomethylation was associated with folate depletion, which was reversible with folate 
repletion(Jacob, Gretz, Taylor, James, Pogribny, Miller, Henning, and Swendseid, 1998). In a 
previous investigation, men did not have hypomethylation with a low folate diet indicating gender 
and/or age may impact the pathways of epigenetic changes from folate deficiency (Jacob, 
Pianalto, Henning, Zhang, and Swendseid, 1995).  
In examining the impact of physical exercise, a recent study assessed whether DNA 
methylation was associated with different levels of physical activity by measuring global genomic 
DNA methylation for LINE-1 in PBMC of participants (n=161) of the North Texas Healthy Heart 
Study (Zhang et al., 2011). The investigators found physical activity of 26-30min/day was 
associated with hypermethylation in PBMC LINE-1 elements compared to those with less than 
24 
 
10min/day of physical activity (Zhang et al., 2011). In another study, the ASC gene, which is 
important for control of IL-1B and IL-18 secretion, was methylated after moderate physical 
exercise (Nakajima, Takeoka, Mori, Hashimoto, Sakurai, Nose, Higuchi, Itano, Shiohara, Oh, and 
Taniguchi, 2010).  
Excessive alcohol consumption may serve as a negative health behavior that can alter 
the epigenome. In an analysis of DNA methylation by PCR-pyrosequencing of data from five 
individual studies, alcohol consumption was inversely associated with Alu methylation, but no 
association was found with smoking; in addition, the percent of lymphocytes in blood counts were 
negatively associated with LINE-1 methylation (Zhu, Hou, Bollati, Tarantini, Marinelli, Cantone, 
Yang, Vokonas, Lissowska, Fustinoni, Pesatori, Bonzini, Apostoli, Costa, Bertazzi, Chow, 
Schwartz, and Baccarelli, 2012).  
Sleep disturbances have also been examined as a potential inducer of epigenetic 
change. In an examination of DNA methylation of Alu, LINE-1, GCR, TNF, and IFNG, shiftworkers 
had significantly different levels of methylation (Bollati, Baccarelli, Sartori, Tarantini, Motta, Rota, 
and Costa, 2010). Furthermore, job seniority was significantly negatively correlated with IFNG 
hypomethylation, and shiftworkers who were described as the ‘morning type’ showed TNF 
hypomethylation which may be related to increased TNF gene expression and subsequent 
increased risk for inflammatory-related diseases (Bollati et al., 2010). 
 
Discussion 
 
Apparent from this review of the literature, little evidence currently exists in humans that 
chronic stressors impact psychosocial and behavioral factors which can lead to epigenetic 
changes to impact immune function. Furthermore, even though epigenetic changes can occur 
throughout life, little work has focused on modifications in adulthood where long-term exposure to 
stressors such as poverty, poor health behaviors, poor psychosocial factors, or environmental 
traumas may be present.  
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Studies cited in this review were cross-sectional or retrospective, providing a snapshot of 
epigenetic changes and altered T cell function or cytokine gene expression. Longitudinal studies, 
particularly those starting in early life, could provide more information about how the epigenome 
changes over time and the impact of various environmental stressors on T cell function and 
cytokine expression; yet, longitudinal studies are challenging to design and implement. Still, it is 
important to develop longitudinal studies to understand the dynamic nature of epigenetic 
changes, immune functions, and stressors over time (Ng, Barrett, Wong, Kuh, Smith, and Relton, 
2012). The reviewed studies also varied substantially in sample size, ranging from 8 participants 
to over 1000 participants. It is important to recruit large sample sizes, particularly for global 
methylation analyses, since a variety of factors in vivo can alter the epigenome and influence the 
gene expression patterns in immune cells. Designing a human epigenetic study controlling for 
confounding factors is crucial to eliminating variables that can limit the validity and reliability of 
reported findings.  
All of the studies in this review utilized samples from peripheral blood or peripheral 
mononuclear cells (PBMCs). While this sample collection method provides a large amount of 
immune cells, it makes it impossible to identify the exact locus of epigenetic change and 
identification of the immune cell subset where functional changes occurred. PBMC contains a 
mixture of immune cells and each individual has different percentages of these cells circulating in 
their blood; thus, it is difficult to tell from these studies if the epigenetic modifications proposed 
are due to actual epigenetic changes or because of variability of cell composition between 
donors.  Thus, the ideal study will need to study the epigenetic modifications in isolated defined 
cell populations and subsets, which require even higher number of cells or blood.  
While epigenetic studies are not a problem for in vitro studies utilizing cell lines or even animal 
models, the large amount of blood necessary for the currently available methodologies examining 
epigenetic change on specific immune cell subsets presents another challenge to conducting 
epigenetic studies in humans. All of the studies cited in this literature review examined global 
methylation patterns via LINE-1 or Alu; this provides a general picture for the methylation status 
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of immune cells, including T cell-related inflammatory cytokine genes. With improvement of new 
technologies such as ChIP-Seq, microarray and RNA-seq, it becomes  possible to analyze the 
epigenetic modifications and gene expression at the genome-wide level (Northrup et al., 2011). 
These new developments could potentially reduce the requirement of cells, improved coverage 
and sensitivity, and reduced cost. Still, it is important to conduct follow-up validation studies on 
specific immune cell subsets and epigenetic loci to understand the exact location and molecular 
modification occurring. 
In conclusion, several models of stress and health (Ingram and Luxton, 2005;Lazarus 
and Folkman, 1984;Lutgendorf and Costanzo, 2003;McEwen, 1998) lack the concept of 
epigenetics as a potential factor mediating the relationship between stress and health outcomes. 
Furthermore, in models of caregiving and health outcomes (Gonzalez, Polansky, Lippa, Walker, 
and Feng, 2011;Pearlin, Mullan, Semple, and Skaff, 1990;Vitaliano, Zhang, and Scanlan, 2003) 
little attention is paid to molecular pathways that may mediate stress-induced psychological or 
behavioral changes, and biological outcomes in health. We understand the negative effects of 
chronic stressors, such as caregiving, on clinical outcomes but face a gap in our knowledge of the 
molecular mechanisms behind stress-induced changes in health. The proposed framework 
(Figure 1) illustrates the potential mediator of epigenetic regulation between stress-induced 
psychosocial and behavioral changes, and immune alterations in family caregivers. This can help 
frame future studies examining the role of epigenetic changes in family caregivers. 
While the studies discussed in this literature review are preliminary, they provide 
interesting findings and support for future investigations to incorporate an epigenetic component 
when examining the impact of psychological and behavioral factors on immune outcomes. Since 
the psychological and behavioral factors examined are also seen in family caregivers, we argue 
future research should be conducted in family caregivers who serve as an ideal clinical model to 
study the effects of stress-induced psychosocial and behavioral changes, and altered immune 
outcomes. Now, as the push to translate bench to bedside science is increasing, it becomes 
important that the role of epigenetic modifications as a mediator between stress-induced 
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psychosocial and behavioral factors, and immune health outcomes are proposed in a framework 
that can be further developed and tested in human populations.  
Table 1. Definitions of Epigenetic-Related Terminology. 
Term Definition 
Epigenetics Epigenetics is one molecular mechanism that controls the transcription 
of genes without altering the DNA sequence (Allis, Jenuwein, & 
Reinberg, 2013) 
DNA methylation DNA methylation is one form of a covalent modification and involves 
the addition of a methyl group onto cytosines at CpG dinucleotides. 
Methylation of cytosines primarily occurs at groupings of CpG rich 
areas called CpG islands; often these islands exist upstream from a 
transcriptional start site giving them significant influence over 
transcription (Lee et al., 2009). 
Histones Histones are the basic components where the DNA wraps around two 
copies of the four core histones (H2A, H2B, H3 and H4) to form 
nucleosomes or ‘beads on a string’ that together form chromatin (Lee 
et al., 2009). 
Histone 
modifications 
Post-translational histone modifications can activate or repress 
transcription depending on the position and type of modification 
(Johnson & Dent, 2013; Northrup & Zhao, 2011). 
Acetylation Acetylation involves the addition of an acetyl group (COCH3) to lysine 
(K) residues and is regulated by histone acetyltransferases (HATs) 
and histone deacetylases (HDACs) (Gong & Miller, 2013); histone 
acetylation is related to activation of transcription, while histone 
deacetylation is associated with repression of transcription (Falvo, 
Jasenosky, Kruidenier, & Goldfeld, 2013). 
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Table 2. Summary of represented epigenetic studies of psychosocial factors.  
 
 Population n 
Sample 
Collection 
Methylation 
Analysis 
Immune Outcome 
PTSD 
African 
American 
adults 
110 
Peripheral 
Blood 
Human 
Methylation27 
BeadChip 
Global methylation was 
increased for PTSD 
subjects and 
inflammatory genes were 
differentially methylated 
including IL4, IL2, TNFa 
Detroit 
Neighborho
od Health 
Study 
100 
Peripheral 
Blood 
HM27 DNA 
Analysis 
BeadChip 
Array 
PTSD subjects had 
unmethylated genes 
related to immune 
function and 
inflammation. Affected 
genes were negatively 
correlated with trauma 
exposure and associated 
with differences in ability 
to mount immune 
response to CMV 
U.S. Army 
and Marine 
service 
members 
75 Serum Pyrosequence 
Increased IL18 promoter 
region methylation and 
protein levels in PTSD 
subjects 
Distress 
Early 
diagnosed 
breast 
cancer 
subjects 
33 
Peripheral 
Blood 
Immuno-
fluorescence 
Reduced nuclear 
acetylation of H4-K8 and 
H4-K12 and reduced 
phosphorylation of H3-
S10 and altered IFNG 
activity in stressed 
diagnosed breast cancer 
subjects 
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Table 3. Summary of represented epigenetic studies of health behaviors  
 
 Population n 
Sample 
Collection 
Methylation Analysis Immune Outcome 
Physical 
Exercise 
 
North 
Texas 
Healthy 
Heart 
Study 
161 
Peripheral 
blood 
MethyLight 
Methylation of 
proinflammatory 
markers 
Health-
Promotion 
Program 
for Elderly 
People in 
Matsuomot
o 
436 
Peripheral 
blood 
Pyrosequencing 
Methylation of ASC 
was higher in older 
exercise group 
compared to older 
control group 
Diet 
Postmenop
ausal 
women 
8 
Peripheral 
blood 
DNA incorporation 
of methyl groups 
inversely related to 
endogenous DNA 
methylation, Method 
of Balaghi and 
Wagner (1993) 
Folate deficiency 
resulted in significantly 
elevated plasma 
homocysteine and 
lymphocyte DNA 
hypomethylation 
Alcohol 
/Smoking 
Five 
studies of 
healthy 
subjects 
1465 
Peripheral 
blood 
Pyrosequencing 
Decreased Alu 
methylation with 
alcohol consumption. 
No associations with 
smoking and 
methylation. Percent of 
lymphocytes in blood 
were negatively 
associated with LINE-1 
methylation 
Irregular 
Sleep 
Shiftwork 
employees 
from 
Northern 
Italy 
150 
Peripheral 
blood 
Pyrosequencing 
Significant difference in 
Alu and gene-specific 
methylation of IFNG 
and TNF promoters in 
morning versus evening 
shiftwork 
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Figure 1. Proposed framework of caregiving stress-induced psychosocial and behavioral 
changes with epigenetic modifications as a mediator of biological immune outcomes. 
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Abstract 
 
Background 
Norepinephrine (NE) is one of the primary catecholamines of the sympathetic nervous system 
released during a stress response and plays an important role in modulating immune function. NE 
binds to the adrenergic receptors on immune cells, including T cells, resulting in either 
suppressed or enhanced function depending on the type of cell, activation status of the cell, 
duration of NE exposure and concentration of NE. Here, we aim to analyze the effects of NE on 
the functionality of naïve (Tn), central memory (Tcm) and effector memory (Tem) CD8 T cells.  
Methods 
We isolated CD8 T cell subsets from healthy human adults and treated cells in vitro with NE 
(1x10-6 M) for 16 hours; we then stimulated NE treated and untreated CD8 T cell subsets with 
antibodies for CD3 and CD28 for 24 and 72 hours. We assessed the level of beta-2 adrenergic 
receptor (ADRB2) expression in these cells as well as global gene expression changes in NE 
treated Tcm cells by microarray analysis. Altered expressed genes after NE treatment were 
identified and further confirmed by RT-qPCR, and by ELISA for protein changes. We further 
determined whether the observed NE effects on memory CD8 T cells are mediated by ADRB2 
using specific adrenergic receptor agonist and antagonists. Finally, we examined the levels of 
mRNA and protein of the NE-induced genes in healthy adults with high serum levels of NE (>150 
pg/mL) compared to low levels (<150 pg/mL).  
Results 
We found that memory (Tcm and Tem) CD8 T cells expressed a significantly higher level of 
ADRB2 compared to naïve cells. Consequently, memory CD8 T cells were significantly more 
sensitive than naïve cells to NE induced changes in gene expressions in vitro. Global gene 
expression analysis revealed that NE induced an elevated expression of inflammatory cytokines 
and chemokines in resting and activated memory CD8 T cells in addition to a reduced expression 
of growth-related cytokines. The effects of NE on memory CD8 T cells were primarily mediated by 
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ADRB2 as confirmed by the adrenergic receptor agonist and antagonist assays. Finally, 
individuals with high serum levels of NE had similar elevated gene expressions observed in vitro 
compared to the low NE group.  
Conclusions 
Our results demonstrate that NE preferentially modulates the functions of memory CD8 T cells by 
inducing inflammatory cytokine production and reducing activation-induced memory CD8 T cell 
expansion.  
 
Keywords: norepinephrine; CD8 T cells; stress; inflammation 
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1. Introduction 
 
A growing body of evidence indicates that the sympathetic nervous system (SNS) modulates 
functions of the immune system (Elenkov et al., 2000;Kin et al., 2006;Sanders et al., 2002). This 
nervous-immune communication is illustrated during a stress response as the SNS releases 
catecholamines, such as norepinephrine (NE), which interact with surface receptors on 
lymphocytes and modulate their functions (Khan et al., 1986;Kohm et al., 2000;Sanders, 2012). 
Chronic stress has detrimental effects on the immune system and to some degree resembles the 
immune changes seen in aging (Gouin et al., 2008;Hu et al., 2014;Kiecolt-Glaser et al., 1996).   
NE is the primary catecholamine released by the SNS and has been previously found to 
significantly impact lymphocytes, including T cells, natural killer (NK) cells and B cells (Kin et al., 
2006;Kohm et al., 2001;Lang, Drell, Niggemann, Zanker, and Entschladen, 2003;Sanders et al., 
2002;Wahle, Hanefeld, Brunn, Straub, Wagner, Krause, Hantzschel, and Baerwald, 2006). The 
effect of NE on immune cells appears complex as NE can have either a stimulatory or inhibitory 
effect depending on the type of immune cell, activation status of the cell, duration of exposure, 
and dosage (Kalinichenko, Mokyr, Graf, Jr., Cohen, and Chambers, 1999;Kin et al., 2006;Kohm 
et al., 2001;Levite, 2000). For example, NE simulates the migratory activity of naïve CD8 T cells 
but inhibits the migration of activated CD8 T cells (Strell, Sievers, Bastian, Lang, Niggemann, 
Zanker, and Entschladen, 2009).  Furthermore, NE exposure reduces IL-2 production and 
upregulates chemokine receptors such as CXCR1 and CXCR2 during CD8 T cell activation (Strell 
et al., 2009).  
CD8 T cells are a heterogeneous population consisting of naïve (Tn) cells and two major memory 
cell populations: central memory (Tcm), which provide a memory reservoir for the rapid response 
to stimulation, and effector memory (Tem), which provide immediate effector functions and 
protective immunity (Sallusto, Geginat, and Lanzavecchia, 2004). It is unknown if the effect of NE 
is similar or different across the CD8 T cell subsets (Tn, Tcm and Tem), which may have in 
different implications on one’s overall immune function.  
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NE binds to the adrenergic receptors expressed on the surface of a variety of immune cells. The 
beta-2 adrenergic receptor (ADRB2) is believed to be the primary receptor on T and B cells 
through which NE directly modulates cellular activity (Padgett et al., 2003;Sanders, 2012;Sanders 
et al., 2003;Sanders et al., 2002). Signaling through the ADRB2 on lymphocytes is one way the 
nervous system regulates the immune system (Nakai, Hayano, Furuta, Noda, and Suzuki, 2014). 
Previous studies have shown the heterogeneous expression of the ADRB2 within peripheral 
blood mononuclear cells (PBMCs) (Anstead, Hunt, Carlson, and Burki, 1998;Khan et al., 
1986;Van Tits et al., 1990), as well as the expression of the ADRB2 on Th1 cells but not on Th2 
CD4 T cells (Kohm et al., 2001;Ramer-Quinn et al., 1997;Sanders, 2012). However, it is unknown 
whether the expression of the ADRB2 is also heterogeneous within CD8 T cell subsets (Tn, Tcm, 
and Tem), or if NE signals mainly through the ADRB2 on CD8 T cells.  
To determine whether NE has a similar or different effect on CD8 T cell subsets and to identify 
the specific changes that occur in CD8 T cells, we compared the ADRB2 expression on CD8 T 
cell subsets (Tn, Tcm and Tem cells) of healthy human donors. In addition, we examined the 
consequences of NE exposure on isolated CD8 T cell subsets’ gene expressions and 
corresponding protein levels, as well as functional changes. To verify these changes were a 
result of NE binding with the ADRB2, we isolated ADRB2 positive and negative memory CD8 T 
cells to examine the impact of NE on cytokine gene expression. We also utilized adrenergic 
receptor agonist and antagonists to determine if the NE effect on gene expression changes in 
memory CD8 T cells are mediated by ADRB2. Finally, we examined this phenomenon in adults 
with either high or low levels of NE in their serum by measuring changes in gene expressions and 
intracellular cytokines of memory CD8 T cells.  
 
2. Materials and Methods 
 
2.1 Human subjects and blood collection 
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Peripheral blood was collected at the clinic of the National Institute on Aging (NIA), National 
Institutes of Health (NIH) from healthy adult donors (N=63) (Supplementary Table 1). PBMCs 
were isolated from the blood and used for the experiment immediately or stored at -80°C for later 
experimental use. To examine potential differences in individuals with either high or low levels of 
NE, we utilized frozen PBMCs from an investigation at the NIH Clinical Center examining 
physiological changes in family caregivers compared to age-, gender- and ethnicity-matched 
normal volunteers (N=32) (Supplementary Table 2) under an Internal Review Board approved 
protocol at the NIH.  
 
2.2 Flow cytometry analysis 
 
For the ADRB2 cell surface staining, freshly isolated PBMCs were incubated with either an 
unlabeled monoclonal antibody against ADRB2 (Abnova) followed by a secondary goat anti-
mouse IgG conjugated with FITC, or by using the same anti-ADRB2 mAb by custom conjugation 
with PerCP/Cy5.5 using a kit (Lightning-Link, Innova Biosciences) according to the 
manufacturer’s instructions. When the secondary goat anti-mouse IgG was used, a non-specific 
mouse IgG was used as a control. Other antibodies used for flow cytometry staining included 
CD8a (APC), CD45RA (PE) and CD62L (FITC) (Biolegend). Samples were analyzed on the BD 
AccuriTM C6 Flow Cytometer. An example of the flow cytometry staining and gating strategy can 
be found in Supplementary Fig. 1. 
For intracellular cytokine staining, frozen PBMCs were thawed and incubated for 3 hours in an 
incubator containing 5% O2.  Next, PMA (50ng/mL, Sigma), Ionomycin (80ng/mL, EMD), and a 
Golgi Blocker (Monensin, 1 µg/million cells, BD Biosciences) were added to the cells and 
incubated for 4 hours. Cells were stained with a viability dye (e506) and antibodies, including CD8 
(PeCy7), CD4 (Pacific Blue), CD3 (ApcCy7), CD28 (APC), CD45RA (FITC) from Biolegend and 
ADRB2 (PerCP/Cy5.5) from Abnova. Cells were washed and then 0.5 ml of fixation buffer 
(Biolegend) was added for overnight incubation at 4°C in the dark. The next day, cells were 
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washed with 1 ml permealization buffer (Biolegend). Intracellular staining for IL-1A (PE) and TNF 
(PerCP/Cy5.5) from Biolegend were completed in one tube, and IL-2 (PerCP/Cy5.5, Biolegend) 
and CCL-2 (PE, eBioscience) in a separate tube. Isotype and fluorescent dye matched non-
specific mouse IgG were used as controls for cytokine staining. Samples were collected on the 
Canto II Flow Cytometer (BD Biosciences). Data and mean fluorescent intensity (MFI) were 
further analyzed using FloJo V10 software. 
We used an antibody against Annexin V and a DNA binding dye, 7-AAD (Biolegend), staining to 
assess cell death and apoptosis at 24 and 72 hours after activation. Samples were analyzed on 
the BD AccuriTM C6 Flow Cytometer, as previously described.  
 
2.3 Isolation and culture of human CD8 T cell subsets from adults with NE 
 
The procedure for isolating naïve and memory CD8 T cells was described previously (Araki et al., 
2009). Briefly, PBMCs were isolated by the Ficoll (GE Healthcare) gradient centrifugation. 
Enrichment of CD8 T cells (naïve and memory) was followed by a negative immunomagnetic 
separation process. Briefly, the removal of other cell types in PBMCs through incubation with a 
panel of mouse mAbs including: CD4, CD11b, CD19, CD14, CD16, MHC class II, erythrocytes, 
platelets, and CD45RO (for naïve cell enrichment) or CD45RA (for memory cell enrichment). The 
antibody bound cells were subsequently removed by the anti-mouse IgG magnetic beads 
(BioMag Goat Anti-Mouse IgG beads, Qiagen). Isolated CD8 T cells were incubated in the 
presence or absence of 1x10-6 M NE (catalog #A7256, Sigma-Aldrich), which was dissolved in 
PBS before being immediately added into human culture media (RPMI1640 with 10% FBS and 
penicillin (10 U/ml)/streptomycin (10 µg/ml)) (Life Technologies) for 16 hours. A NE concentration 
of 1x10-6 M is considered physiologically relevant (Sanders, 2012;Strell et al., 2009;Torres et al., 
2005;Wahle et al., 2006). The next day, NE-treated or untreated CD8 T cells were further sorted 
into naïve (CD45RA+, CD62L+), central memory cells (CD45RA-, CD62L+) and effector memory 
cells (CD62L-, CD45RA-) by a cell sorter (MoFlo, Dako Cytomation). The purity of sorted naïve 
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and memory CD8 T cells was >96%. Isolated CD8 T cell subsets were either used for gene 
expression analysis immediately or incubated at 5% O2, with anti-CD3/28-coupled beads at a 
cell:bead ratio of 1:1 in human culture media, and harvested at the indicated time for analyses of 
mRNA. In addition, the culture supernatant was collected for cytokine protein analysis.  
For isolation of naïve and memory CD8 T cells from cryopreserved PBMCs of human adults, 
PBMCs were thawed in a 37°C water bath, washed and resuspended in RPMI. Naïve and 
memory (Tcm+Tem) CD8 T cells were isolated by a cell sorter (MoFlo, Dako Cytomation) using 
the following staining: Viability dye (e506), CD8+, Naive (CD45RA+, CD28+), and memory (CD28+ 
-). The purity of sorted naïve and memory CD8 T cells was >96%. 
 
2.4 Gene expression analysis by microarray 
 
Genome-wide gene expression analysis was performed on NE-treated and untreated CD8 Tcm 
cells before and after anti-CD3/CD28 beads stimulation (24 and 72 hours) using Agilent’s whole 
genome array (SurePrint G3 Human GE 8x60K V2 Microarray Kit, Agilent Technologies).  Three 
biological repeated samples were used for the resting and 24 hour time points, and two biological 
repeated samples for 72 hours were used. Each sample consisted of pooled RNA from 3 different 
donors, based on the manufacturer’s instruction. Briefly, RNA was isolated from cells (RNeasy 
Mini Kit, Qiagen) and the integrity and quality of the RNA was tested using the Bioanalyzer Chip 
(Agilent). 
 Next, a two-color microarray-based gene expression analysis of ~60,000 genes/transcripts was 
conducted according to the manufacturer’s instructions. We started with 100 ng of total RNA of 
the sample and human universal reference RNA for labeling using the Low Input Quick Amp 
Labeling Kit based on the manufacturer’s instructions. The labeled probes were quantified by 
NanoDrop ND-1000 UV-VIS Spectrophotometer version 3.2.1 (G4851B, Agilent). Samples were 
hybridized onto whole human genome 8x60K array slides for 17 hours at 65°C in a rotator oven, 
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followed by washing with appropriate Wash Buffers (Agilent). Hybridization signals were extracted 
via the Agilent Feature Extraction Software.  
Two-color microarray data was first extracted from the Agilent reader, and was log-normalized 
relative to the reference color. Data was batch normalized and significant outliers were filtered 
using custom ‘perl’ scripts. Determination of the most significantly different gene ontology (GO) 
groups was done through Broad Institute’s Gene Set Enrichment Analysis (GSEA) tool (Mootha, 
Lindgren, Eriksson, Subramanian, Sihag, Lehar, Puigserver, Carlsson, Ridderstrale, Laurila, 
Houstis, Daly, Patterson, Mesirov, Golub, Tamayo, Spiegelman, Lander, Hirschhorn, Altshuler, 
and Groop, 2003;Subramanian, Tamayo, Mootha, Mukherjee, Ebert, Gillette, Paulovich, 
Pomeroy, Golub, Lander, and Mesirov, 2005). We utilized the Biological Processes sub-category 
of the GO groups provided by Broad Institutes’ Molecular Signature Database. Groups were 
deemed significant at a FDR q-value of 0.25 or below. Genes of interest for each group were 
extracted based on the core enrichment value provided by GSEA. The pre-activation time point 
was studied alone; however, the post-activation 24-hour and 72-hour time points were combined 
into a single group during GSEA analysis. The entire microarray data set was deposited in the 
GEO database (GSE64635).    
 
2.5 Quantitative RT-PCR of mRNA of human donors  
 
The procedure for real time quantitative PCR (RT-qPCR) was described previously (Araki et al., 
2009). Briefly, RNA was isolated using the RNeasy Mini Kit with Qiacube (Qiagen) and cDNA was 
synthesized with oligo-dT and random hexamers (Life Technologies) with 60ng of RNA. Primer 
sequences can be found in the Supplementary material (Supplementary Table 3). The mRNA 
levels were determined by quantitative RT-PCR using 2x SYBR Green PCR Master Mix (Fisher 
Scientific) and normalized to a lymphocyte housekeeping gene, acyl-Coenzyme A oxidase 1 
(ACOX1), as described previously (Araki et al., 2009). PCR was performed on 7900HT Fast Real-
Time PCR System (Applied Biosystems).  
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2.6 Measurement of cytokine protein by ELISA  
 
Culture supernatants from CD8 T cell subsets were collected before, 24 hours, and 72 hours after 
anti-CD3/CD28 stimulation. The amount of cytokine proteins was determined by an ELISA kit 
(ELISA Max Deluxe Set Human: IL-2, IL-6, MCP-1, IL-1A, TNF, IFN-γ, Biolegend) according to 
the manufacturer’s instructions. Concentrations were calculated according to the standard, and 
normalized to the number of cells among different samples. 
 
2.7 Assay for Adrenergic Receptor agonist and antagonists 
 
To verify if the ADRB2 is the primary receptor for NE on memory CD8 T cells, we isolated 
ADRB2+ and ADRB2- memory CD8 T cells by a cell sorter using anti-ADRB2 mAb by custom 
conjugation with PerCP/Cy5.5, as described in the above section.  We also isolated memory CD8 
T cells via a negative immunomagnetic separation described in Methods 2.3 for testing the 
ADRB2 agonist and antagonists. The purity of isolated memory CD8 T cells was ~82% (no 
detectable naïve CD8 or CD4 T cells) and had comparable changes in cytokine expression by NE 
and its agonist and antagonists when memory CD8 T cells were isolated by a cell sorter (data not 
shown).  
To further determine that ADRB2 is the primary receptor for NE, we added Terbutaline (ADRB2 
agonist, catalog #T2528, Sigma-Aldrich) at a concentration of 10-5 M and incubated for 16 hours 
before activation. For the antagonist experiments, Nadolol (beta-adrenergic receptor antagonist 
(ADRB), catalog #N1892, Sigma-Aldrich) or Phentalomine (alpha-adrenergic receptor (ADRA) 
antagonist, catalog #P7547 Sigma-Aldrich) were added at 10-5 M at the same time as NE. We did 
serial dilutions (10-3, 10-5 and 10-8 M) of the agonist and antagonists based on previous reports 
and found 10-5 M to be the most effective dose after titrating the agonist and antagonists (data not 
shown). The treated CD8 T cells were stimulated with CD3/CD28 antibodies. Treated cells were 
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harvested and the culture supernatants were collected before and 24 hours after activation for 
RT-qPCR and ELISA analyses, respectively.  
 
2.8 NE measurements in serum 
 
NE was measured in the serum of all donors as described previously (Eisenhofer, Goldstein, 
Stull, Keiser, Sunderland, Murphy, and Kopin, 1986). Briefly, peripheral blood was collected after 
a 15 minute rest period and placed on ice until processed and stored at -80°C (Eisenhofer et al., 
1986). When thawed, NE was measured using standard high-performance liquid chromatography 
(HPLC) with electrochemical detection that has been previously established for simultaneous 
measurement of the concentrations of catecholamines; quantification of NE was detected with a 
triple-electrode system. The designation of 150 pg/mL for the high or low NE level in serum was 
reached by averaging the 3 time points donors had their NE levels measured during a 3 month 
timeframe and finding the approximate median among the donors. NE levels did not differ 
significantly between time points in the donors. Utilization of these samples and the primary 
investigation where the samples originated was approved by the Internal Review Board at the 
National Heart Lung and Blood Institute (NHLBI), NIH and the University of Pennsylvania. 
 
2.9 Statistics 
 
Data are expressed as the mean ± SEM and significance was assessed using the paired 
Student’s t-test. p < 0.05 was considered significant. 
 
3. Results 
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3.1 ADRB2 is highly expressed in the memory subsets compared to the naïve subset of 
CD8 T cells 
 
Previous studies have found that ADRB2 is heterogeneously expressed on different immune cells 
(Anstead et al., 1998;Kohm et al., 2001;Sanders, 2012), yet the expression of ADRB2 on CD8 T 
cell subsets is not known. We first assessed the surface expression of ADRB2 by flow cytometry 
on the 3 subsets of CD8 T cells (Tn, Tcm and Tem) in the PBMCs of healthy human adults (Fig. 
1A). We found that the memory populations (Tcm and Tem) of CD8 T cells expressed a 
significantly higher percentage (~40%) of ADRB2 compared to the Tn population (~10%) (Fig. 
1B). Furthermore, memory CD8 T cells also expressed significantly more ADRB2 on average 
compared to Tn cells as measured by MFI with flow cytometry (Fig. 1C). To further determine if 
ADRB2 expression is regulated by transcription, we assessed the mRNA level of ADRB2 in Tn, 
Tcm and Tem and found greater expression (0.61 fold higher) in memory CD8 T cells (Tcm and 
Tem) compared to Tn cells (Fig. 1D). Together, our findings show that ADRB2 is highly 
expressed in memory CD8 T cell populations compared to the Tn population. 
 
3.2 NE induces expression of inflammatory cytokines and chemokines in memory CD8 
cells  
 
The effect of NE on the expression of several cytokines in CD8 T cells has been reported 
(Kalinichenko et al., 1999;Sanders, 2012;Strell et al., 2009), but a genome-scale assessment of 
NE-induced changes in CD8 T cells has not been conducted. We focused on Tcm cells because 
of their critical role in the recall response for adaptive immunity and their high level of ADRB2 
expression. To determine the overall impact of NE on human CD8 T cells, we conducted a 
genome-wide analysis of gene expression changes in CD8 Tcm cells after NE exposure using a 
microarray. CD8 Tcm cells were isolated from healthy adults and treated with NE for 16 hours 
before stimulation with antibodies against CD3 and CD28 (anti-CD3/CD28), and harvested before 
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and 24, 72 hours after stimulation for gene expression analyses. Genes with the greatest degree 
of changes after NE treatment were identified (Supplemental Table 4). 
A functional assessment using GSEA of altered gene expressions by NE treatment revealed 
important biological and immunological functions, including regulation of cell differentiation, cell 
cycle process and MAPK activity (Fig. 2A). Among the NE induced genes that were identified 
based on GSEA and fold changes, we focused on the inflammatory cytokines and relied on RT-
qPCR method to confirm and extend our analysis to other inflammatory cytokines in all CD8 T cell 
subsets (Tn, Tcm and Tem). We found that Tcm and Tem exhibited a similar upregulation of IL1A 
and IL6, while Tn cells did not show a significant difference in expression between NE treated 
and untreated cells (Fig. 2B). Both IL1A and IL6 have multiple, important functions in 
inflammation (Ershler and Keller, 2000). In addition, several chemokines related to the 
inflammatory and chemoattraction processes were also upregulated in the NE treated cells, 
including CXCL1, CXCL2, CXCL3 and CCL2, as determined by the RT-qPCR method (Fig. 2C).  
Next, we assessed whether the NE induced changes observed at the mRNA level correlate with 
the protein level. We then measured protein levels of selected cytokines and chemokines in the 
culture supernatant of the memory CD8 T cells by ELISA. Since NE treated Tn cells did not show 
any significant gene expression changes, we did not further investigate this population. A similar 
increase in the protein levels of IL-1A and CCL-2, but not IL-6 were observed (Fig. 2D). Together, 
these results demonstrate that memory CD8 T cells were more susceptible to the effects of NE 
than the naïve CD8 T cell subset, and suggest that NE exposure induces a pro-inflammatory 
state in memory CD8 T cells.  
 
3.3 Activation induces greater expression of inflammatory cytokines and chemokines in 
NE treated memory CD8 cells  
 
We next asked what impact NE would have on memory CD8 T cells in response to activation and 
again found several cytokines and chemokines significantly upregulated (top 100 most altered 
44 
 
genes after activation are identified in Supplemental Table 5). Using GSEA, we identified the 
altered biological and immunological functions in NE-treated Tcm CD8 cells (Fig. 3A). We again 
focused on the inflammatory cytokines and relied on RT-qPCR method to confirm and extend our 
analyses to other inflammatory cytokines in memory CD8 T cells (Tcm and Tem).   
Among the altered expressed genes, IL6, CXCL2, CXCL3, and CCL2 were upregulated with NE 
treatment before activation and remained upregulated after activation compared to controls (Fig. 
3B). Furthermore, two pro-inflammatory cytokines (TNF and IL36G) and a chemokine (CCL8) 
were upregulated in NE treated memory CD8 T cells only after activation (Fig. 3C).  We 
examined TNF specifically since it is a well-known pro-inflammatory cytokine involved in 
inflammatory-related diseases. CCL8, a chemokine involved in several immune-regulatory and 
inflammatory processes, exhibited a similar enhanced expression pattern to TNF, whereas 
IL36G, participating in local inflammatory responses, showed an increased enhancement of 
expression from 24 to 72 hours compared to the control (Fig. 3C).  
Protein levels of TNF, IL-6 and CCL-2 in the culture supernatant correlated with the gene 
expression changes at 24 and 72 hours after activation (Fig. 3D). We observed an average four-
fold increase in the protein level of TNF compared to a two-fold difference in IL-6 and CCL-2. In 5 
of the 6 cases, the most significant difference in protein levels between untreated and treated 
memory CD8 T cells was observed at 24 hours.  
 
3.4 Activation induces lower expression of growth-related genes in NE treated memory 
CD8 T cells and consequently reduces activation-induced expansion of CD8 T cells 
 
 In contrast to the enhanced expression of inflammatory cytokines in NE-treated memory 
CD8 T cells before and after stimulation, we also identified two growth-related cytokines (IL2 and 
IFNG) whose expression levels were reduced in NE-treated memory but not naïve CD8 T cells 
after stimulation. IL2 met both criteria of the altered gene expression by the microarray and RT-
qPCR; however, IFNG did not meet the criteria of our microarray, but was confirmed by RT-qPCR 
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as significantly altered with NE treatment (Fig. 4A). IL2 is an important growth factor and IFNG 
has been previously shown to promote the growth of memory T cells (Asao and Fu, 
2000;Kryczek, Wei, Gong, Shu, Szeliga, Vatan, Chen, Wang, and Zou, 2008;Zhang, Sun, Hwang, 
Tough, and Sprent, 1998). The reduced expressions of IL2 and IFNG were further confirmed at 
the protein levels in the culture supernatant of stimulated memory CD8 T cells (Fig. 4B). These 
findings suggest that NE has an immunosuppressive effect on memory CD8 T cells by 
significantly down-regulating cytokines critical for the proliferation of CD8 T cells.  
 To determine the impact of the reduced expression of growth-related cytokines such as 
IL-2 and IFN-γ, we assessed the activation-induced expansion of memory CD8 T cells and 
observed a significant reduction in the cell number of NE treated CD8 Tcm cells 24 hours after 
activation compared to the NE untreated CD8 Tcm cells (Fig. 4C). To rule out the potential role of 
cell death in the differences in activation-induced expansion, we analyzed cell viability and found 
no significant difference in the viability of Tcm cells between NE treated and untreated Tcm cells 
at baseline, 24 or 72 hours after activation (Fig. 4D).  
 
3.5 NE effect on memory CD8 T cells is mediated by ADRB2  
 
NE can bind to other adrenergic receptors aside from the ADRB2 (Ramer-Quinn et al., 1997). To 
determine if ADRB2 was responsible for the observed NE effects on memory CD8 T cells, we 
isolated ADRB2+ and ADRB2– CD8 memory T cells with a cell sorter. The effects of NE on the 
expression of IL1A and IL6 (before activation), and IL2 and TNF (after 24 hour activation) were 
significantly greater in the ADRB2+ than in the ADRB2– memory CD8 T cells (Fig. 5A). To further 
determine whether the effects of NE were through ADRB2 but not ADRB1, we treated resting 
memory CD8 T cells with an ADRB2 agonist, Terbutaline, and found it induced an 
indistinguishable level of changes in mRNA and protein levels of IL1A and IL6 compared to the 
NE treated memory CD8 T cells (Fig. 5B and 5C). We also determined if NE stimulates the 
ADRB2 specifically by exposing memory CD8 T cells to NE in the presence or absence of either 
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the beta-adrenergic receptor (ADRB) antagonist (Nadolol) or the alpha adrenergic receptor 
(ADRA) antagonist (Phentalomine). Blocking ADRB with Nadolol abolished the NE effect on IL1A 
and IL6 but blocking ADRA with Phentalomine did not have an obvious impact on NE’s effect on 
IL1A and IL6 expression (Fig. 5B and C), suggesting NE’s effect on memory CD8 T cells is 
primary mediated by ADRB2, but not by ADRA. We extended the antagonist analysis to 
activation-induced changes in gene expression affected by NE and observed a similar response: 
Terbutaline mimicked NE’s effect; Nadolol blocked NE’s effect, and Phentalomine did not block 
NE’s effect on IL2 and TNF expression (Fig. 5D and E).  
 
3.6 High blood NE levels are associated with enhanced expression of inflammatory 
cytokines in memory CD8 T cells  
 
Our in vitro experiments illustrate a previously unknown effect of NE inducing greater expression 
of inflammatory cytokines in memory CD8 T cells. We next asked if these findings would exist in 
an in vivo model by analyzing the relationship of blood NE levels and inflammatory cytokine 
expressions in memory CD8 T cells in 32 adults participating in a primary investigation examining 
the effects of chronic stress on health outcomes. Subjects who participated in this study had their 
serum NE level measured at each visit with a total of 3 measurements over approximately 3 
months. Based on the approximate median of the blood NE levels, we grouped subjects into two 
groups: high (>150 pg/mL) and low NE levels (<150 pg/mL) (Fig. 6A). We isolated memory and 
naïve CD8 T cells from frozen PBMCs of these subjects by a cell sorter and analyzed the 
expression of inflammatory cytokines identified from our in vitro work with RT-qPCR and flow 
cytometry.  
We found that IL1A and TNF were significantly higher in memory CD8 T cells of the high NE 
group than the low NE group, whereas IL2 was significantly lower in memory CD8 T cells of the 
high NE group compared to the low NE group (Fig. 6B). We then measured the protein levels of 
these 3 cytokines via intracellular staining with flow cytometry. We found adults in the high NE 
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group had significantly higher percentages of memory CD8 T cells expressing IL-1A and TNF, but 
a significantly lower percentage of memory CD8 T cells expressing IL-2 (Fig. 6C).  
  
4. Discussion 
 
 Here we conducted a comprehensive assessment of how NE modulates CD8 T cell 
subsets by examining ADRB2 expression, transcriptional and protein level alterations, and 
activation-induced expansion in both an in vitro condition using a physiological relevant 
concentration of NE, and in an in vivo setting using a study cohort with known serum NE levels. 
Our results demonstrate that ADRB2 is highly expressed in memory CD8 T cells, revealing the 
preferential effect of NE on memory CD8 T cells. Furthermore, we found that NE induces 
inflammatory cytokine production while simultaneously reducing production of growth-related 
cytokines, leading to a reduced activation-induced expansion of memory CD8 T cells. Ultimately, 
this indicates a two-sided effect of NE on memory CD8 T cells. Finally, we show that a high 
serum concentration of NE is associated with a high expression of inflammatory cytokines and a 
low expression of growth-related cytokines in the memory CD8 T cells of stressed adults. NE’s 
preferential impact on memory CD8 T cells may help improve our understanding of the 
mechanisms of NE in chronic stress-associated immune-related disorders such as viral and 
bacterial infections (Farias, Teixeira, Moreira, Oliveira, and Pereira, 2011;Kemeny et al., 2007). 
 ADRB2 is known to be expressed differently in different type of cells within PBMCs and 
believed to be the main receptor for NE (Sanders, 2012). Our study extends these findings by 
showing ADRB2 is differentially expressed on naïve and memory CD8 T cells. Fewer naïve CD8 
T cells express ADRB2, but significantly more antigen-experienced memory CD8 T cells express 
ADRB2. Furthermore, ADRB2 is significantly more abundant on memory than naïve CD8 T cells. 
Previous studies also show that ADRB2 plays a critical role in regulating the immune function of 
lymphocytes (Anstead et al., 1998;Bonneau et al., 1990;Khan et al., 1986;Mills et al., 2004;Mills, 
Ziegler, Patterson, Dimsdale, Hauger, Irwin, and Grant, 1997). Here, we demonstrate memory 
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CD8 T cells expressing ADRB2 respond to NE, but memory CD8 T cells that are ADRB2 negative 
do not respond to NE. The effect of NE on memory CD8 T cells is primarily through ADRB2, as 
supported by the results from the receptor agonist and antagonists assays. The ADRB2 agonist 
was able to mimic the changes induced by NE at the mRNA and protein level. The alpha 
antagonist showed no effect on NE-induced changes in expression of the four cytokines tested, 
while the beta adrenergic antagonist almost completely blocked NE’s effect on these cytokines. 
Our findings suggest that ADRB2 is the primary receptor for NE, and ADRA does not play a 
measurable role in NE-induced memory CD8 T cell changes. Our findings demonstrate for the 
first time that ADRB2 expression in CD8 T cells is differentially regulated and the impact of NE is 
preferentially on memory CD8 T cells. Further studies need to be conducted to provide further 
insight into the mechanisms behind altered cytokine production in memory CD8 T cells following 
NE binding to the ADRB2. 
 Chronic stress and inflammation is intricately linked via a network of interactions 
mediated by neurotransmitters and hormones (Carlson, Brooks, and Roszman, 1989;Levite, 
2000;Straub, Westermann, Scholmerich, and Falk, 1998). NE is also implicated in the 
inflammatory response through a variety of pathways, one of them being the regulation of IFN-γ 
production in immune cells (Dhabhar et al., 2012;Dimsdale, Mills, Patterson, Ziegler, and Dillon, 
1994;Mausbach, Dimsdale, Ziegler, Mills, Ancoli-Israel, Patterson, and Grant, 2005;Sperner-
Unterweger et al., 2014). However, the global scope and the type of T cell subsets that respond 
to NE have not been previously addressed. Our global gene expression analysis of memory CD8 
T cells before and after activation reveals some unexpected and rich findings of NE-induced 
production of a large panel of inflammatory cytokines by memory CD8 T cells. Interestingly, we 
found NE induced an inflammatory state in memory CD8 T cells even before the cells were 
activated. Cytokines genes such as IL6 and TNF play an important role in the pro-inflammatory 
response as well as a variety of other immune responses. Chemokines discussed such as CCL2, 
CXCL1 and CXCL3 also mediate inflammatory responses as well as having important 
chemotactic activity for lymphocyte and monocyte migration. After activation, some of the same 
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inflammatory cytokines and chemokines were still significantly increased as well as some new 
inflammatory markers.  
Previous studies have shown the inhibitory impact of NE on immune cells (Kalinichenko et al., 
1999;Kohm et al., 2000;Kohm et al., 2001;Lang et al., 2003;Malarkey, Wang, Cheney, Glaser, 
and Nagaraja, 2002;Ramer-Quinn, Swanson, Lee, and Sanders, 2000;Swanson et al., 2001), 
including CD8 T cells and the alteration in IFN- and IL-2 production (Strell et al., 2009;Torres et 
al., 2005;Wahle et al., 2006). Our study supports these findings by showing a reduction in the 
expression of IFN- and IL-2 in NE treated memory CD8 T cells. The decrease in IL-2 and IFN- 
production explains, in part, the modest decrease in cell number found in NE treated cells after 
stimulation, which may play a role in altering the proliferation of NE treated compared to 
untreated memory CD8 T cells. However, the precise intracellular pathways leading to these 
transcriptional and protein changes requires further investigation.  
Findings from our study of CD8 T cell subsets may help explain the conflicting findings of 
previous studies looking at the effect of NE on immune cells to be immune suppressive, immune-
enhancing, or null (Dhabhar et al., 2012;Kin et al., 2006;Strell et al., 2009). By studying immune 
cells in PBMCs rather than specific cell types, or even subsets (naïve or memory), the actual 
effects of NE on a subset of lymphocytes can be masked by the larger group of other types of 
immune cells. Future studies will benefit from utilizing defined types of immune cells and their 
subsets to draw out the impact of NE on these cells. Memory CD8 T cell sensitivity to NE may 
have clinical relevance since memory cells are responsible for recall immune responses as 
opposed to naïve cells that fight off new challenges. An individual with high levels of NE may be 
more compromised in terms of fighting off recall infections rather than new antigenic challenges. 
 Compared to our in vitro findings under controlled conditions, in vivo changes are likely 
influenced by multiple factors. It is therefore reassuring to find that some inflammatory-related 
cytokines and chemokines in adults with high blood levels of NE are also elevated in memory 
CD8 T cells compared to low blood levels of NE; these findings are similar to the inflammatory 
response we observed in vitro. We also examined other cytokines and chemokines (CCL2, IFNG, 
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IL6, CXCL1, and CCL8) but did not find significant differences between the high and low groups. 
There was also no difference in ADRB2 expression between the high or low NE groups in 
lymphocytes, Tn, or Tm cells (Supplementary Fig. 2). It is important to note that the effects 
observe in vivo could be a result of a combined influence from hormones and neurotransmitters 
including NE directly or indirectly (Straub et al., 2000;Straub et al., 1998). Nevertheless, NE 
appears to play an important role in modulating CD8 T cell function, particularly in memory cells.  
The impact of chronic stress on immune function is undoubtedly complex.  More work needs to 
be done to better understand the impact of NE on CD8 T cells as well as on other types of 
lymphocytes such as CD4 and B cells. Investigating the effect of NE under defined in vitro 
conditions and some suitable in vivo settings will help to elucidate the role of NE in modulating 
immune function. Future work should also focus on the clinical implications of high NE levels, 
particularly on immune health outcomes as well as interventions to alleviate the effects of stress 
on the immune system.  
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Figure 1. ADRB2 is highly expressed in the memory subsets compared to the naïve CD8 T 
cells (A) Representative figures of the flow cytometry staining for ADRB2 expression on CD8 T 
cell subsets. Lymphocytes were gated from the peripheral mononuclear cell (PBMC) sample 
followed by a CD8+ T cell (APC) gate. CD8 T cell subsets, naïve (CD45RA+CD62L+), central 
memory (CD45RA-CD62L+) and effector memory (CD45RA-CD62L-) cells were gated for 
measure of ADRB2 expression. Staining for ADRB2 was described in the Methods. (B) ADRB2 
expression in individual CD8 T cell subsets. ADRB2 expression is presented as a percentage for 
each CD8 T cell subset: naïve (Tn), central memory (Tcm) and effector memory (Tem). There 
was significant difference in ADRB2 percentage of expression between Tn and memory (Tcm and 
Tem) T cells (N=50, p<0.001). (C) Mean fluorescent intensity (MFI) of ADRB2 expression in CD8 
T cell subsets. The MFI of each CD8 T cell subset was measured to examine ADRB2 on the 
average of each type of cells. Per subject, memory CD8 T cells expressed significantly more 
ADRB2 compared to naïve cells (N=50, p<0.001).  (D) ADRB2 expression on the mRNA level of 
Tn, Tcm and Tem subsets in healthy human adults by RT-qPCR. Data is presented as the 
relative mRNA expression in the LOG10 value (N=6). Figures throughout this manuscript 
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illustrated the results with the mean and SEM. Significance is identified as follows: * p<0.05, ** 
p<0.01, *** p<0.001 
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Figure 2. Increased gene expression of inflammatory cytokines in CD8 Tcm cells treated with 
norepinephrine. (A) Relevant Gene Ontology (GO) groups extracted from GSEA comparison 
between NE treated and untreated CD8 Tcm cells before activation. These groups had significant 
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FDR q-values (<0.25), and representative genes were chosen from the set of core enriched 
genes, also derived from GSEA. (B) and (C) Significantly increased inflammatory cytokines and 
chemokines (mRNA) after NE treatment. RT-qPCR was done based on the microarray results for 
the selected cytokine genes significantly increased by NE treatment. Results are presented as a 
ratio (NE/Control) on the Log2 scale for the naïve (Tn), central memory (Tcm) and effector 
memory (Tem) subsets of CD8 T cells (N=7-11).  (D) Protein levels of the selected cytokines and 
chemokines altered by NE treatment examined via ELISA. Results are presented as the 
concentration (ng/mL) of the cytokine or chemokine in the controls (untreated) and NE treated 
central memory (Tcm) and effector memory (Tem) cells at 0 hours (N=6-14).   
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Figure 3. Activation induces greater expression of inflammatory cytokines and chemokines in 
norepinephrine treated memory CD8T cells. (A) Relevant Gene Ontology (GO) groups extracted 
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from GSEA comparison between treated and untreated CD8 Tcm cells after activation. These 
groups had significant FDR q-values (<0.25), and representative genes were chosen from the set 
of core enriched genes, also derived from GSEA. (B) Significantly increased inflammatory 
cytokines and chemokines (mRNA) in NE treated CD8 T cells before and activation. Results are 
presented as a ratio (NE/Control) on a LOG2 scale for 0, 24, and 72 hours in Tcm and Tem cells 
(N=6-14). (C) Significantly increased inflammatory cytokines and chemokines (mRNA) in NE 
treated CD8 T cells only after activation. Data is presented as a ratio (NE/Control) on a LOG2 
scale for 0, 24, 72 hours in Tcm and Tem cells (N=6-14). (D) Protein level expression of selected 
cytokines and chemokines at 0, 24, 72 hours after activation in untreated (control) and NE treated 
Tcm and Tem cells. Data is presented as the concentration (ng/mL) (N=6-12). 
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Figure 4. Activation of NE treated memory CD8 T cells led to decreased expression of IL2 and 
IFNG in the memory subsets resulting in a reduced activation-induced expansion. (A) Decrease 
in proliferation-related cytokines, IL2 and IFNG, at the mRNA level in memory CD8 T cells. RT-
qPCR was used for confirmation of microarray results as well as examining gene expression 
changes in the naïve (Tn) and effector memory (Tem) subsets. Results are presented as a ratio 
(NE/Control) in the LOG2 value from baseline to 24 and 72 hours after activation (N=6-14). (B) 
Protein levels of memory subsets (Tcm and Tem) as measured by ELISA at baseline, 24 and 72 
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hours after activation in control and NE treated cells. Data is presented as the concentration 
(ng/mL) (N=7-12). (C) Cell counts of Tcm cells at 24 and 72 hours after activation. Results are 
presented as the ratio (NE/Control) at 24 and 72 hours after activation in central memory (Tcm) 
cells (N=15). (D) Viability of Tcm cells was examined by viability dye (7AAD) and apoptosis dye 
(Annexin V) at 0, 24 and 72 hours after activation. Data is presented as the percentage of live 
cells which was determined by the gated Tcm cells followed by 7AAD- and Annexin V- gated cells 
in flow cytometry of the NE treated and untreated cells (N=10). 
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Figure 5. NE action in memory CD8 T cells is mediated by ADRB2. (A) ADRB2+ CD8 Tcm cells 
respond to NE treatment. We isolated ADRB2+ and ADRB2- CD8 Tcm cells from the blood of 
human donors. Relative mRNA levels of cytokines in the ADRB2+ cells compared to ADRB2- cells 
before (IL1A and IL6) and 24 hours after activation (IL2 and TNF) are presented (N=6). (B) The 
effect of ADRB2 agonist and antagonists on NE-induced cytokine expression (mRNA) before 
activation. Memory CD8 T cells were isolated and cultured with NE or an ADRB2 agonist 
(Terbutaline) alone or NE plus an antagonist (either an ADRB antagonist (Nadolol) or an ADRA 
antagonist (Phentalomine)). Relative expression changes of IL1A and IL6 under these treatments 
are presented (N=12). (C)  The effect of the adrenergic receptor agonist and antagonists on NE-
induced cytokine expression (protein) before activation. Similar changes of IL-1A and IL-6 protein 
concentration levels (ng/ml) in the culture supernatant under the treatments of the agonist 
(Terbutaline) and antagonists (Nadolol or Phentalomine) are presented (N=8). (D) The effect of 
the adrenergic receptor agonist and antagonists on NE induced cytokine expression (mRNA) 
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after activation. Relative levels of IL2 and TNF mRNA changes after 24 hours of activation under 
NE alone, Terbutaline alone, NE plus Nadolol, and NE plus Phentalomine are presented (N=12). 
(E) The effect of the adrenergic receptor agonist and antagonists on NE induced cytokine 
expression (protein) after activation.  IL-2 and TNF protein concentration levels (ng/ml) in the 
culture supernatant under the treatment of the agonist (Terbutaline) and antagonists (Nadolol or 
Phentalomine) are presented (N=8).  
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Figure 6. Altered inflammatory cytokines in adults with higher levels of norepinephrine. (A) 
Blood NE levels in study subjects. Blood NE levels are separated into two groups based on the 
approximate median: low NE levels (<150 pg/mL) (N=18) and high NE levels (>150 pg/mL) 
(N=14). Data is shown as NE levels measured in the serum (pg/mL) in the two groups (low and 
high) in which the following analyses were conducted. (B) Gene expression changes between the 
low NE group and the high NE group examined using RT-qPCR. Data is presented as the LOG10 
value (N=9 for high and N=6 for the low blood NE group). (C) Cytokine protein levels (IL-2, IL1-α, 
TNF) in memory CD8 T cells measured by intracellular staining between the low and high NE 
groups. Data is presented as the percentage of cells in each group (N=14-17 for high and N=17-
22 for the low NE group). 
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Supplemental Table 1. List of donors for the in vitro portion of this study with their age, 
gender and experimental use. An ‘X’ indicates the donor was used for the experiment. 
Donor 
ID 
Gender Age Experiment 
   
ADRB2 
Staining 
Array RT-qPCR Elisa 
Agonist/ 
Antagoni
st 
1 F 22 X     
2 M 23 X     
3 F 25 X  X X X 
4 M 25 X    X 
5 M 25 X     
6 F 27 X     
7 F 28 X X X X  
8 F 28 X     
9 M 29  
 
X X  
10 F 29 X     
11 M 30 X     
12 F 30 X     
13 F 32   X X X 
14 F 32  X  X X 
15 M 34 X X X X  
16 F 34 X     
17 M 35  X X X  
18 F 35 X 
 
X X  
19 M 35 X     
20 M 35 X     
21 M 36 X     
22 F 37 X  X  X 
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23 F 37   X X  
24 M 38 X X X X  
25 F 39 X  X X  
26 M 39 X X    
27 F 39 X     
28 M 40 X 
 
X X X 
30 F 40 X     
31 F 42   X X  
32 M 43  
 
X X X 
33 F 43  
 
X X X 
34 M 43 X     
35 M 45   X X  
36 M 44   X X X 
37 M 47  
 
X X  
38 F 49 X 
 
X X  
39 F 49 X 
 
X X  
40 F 49 X X X X  
41 M 53 X  X X  
42 F 57 X X X X X 
43 F 57 X    X 
44 M 59 X 
 
X X  
45 M 60 X 
 
X X  
46 F 64 X 
 
X   
47 M 66 X X X X  
48 M 67 X  XX  X 
49 M 68 X  X   
50 M 69 X 
 
X X  
51 M 69 X  X   
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52 M 70 X X X X  
53 M 71 X  X   
54 F 72 X X X   
55 M 72 X  X   
56 F 73 X 
 
X X  
57 F 73 X X X   
58 M 74 X  X X  
59 M 75 X  X   
60 M 78 X X X X  
61 M 81 X  X   
62 F 82 X  X   
63 F 85 X X X   
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Supplemental Table 2. List of donors for the in vivo portion of this study with their age, 
gender, and experimental use. An ‘X’ indicates donor was used for the experiment. 
Donor ID Age Gender Experiments 
   
Cell sorted/ 
RT-qPCR 
Flow 
Cytometry 
1 30 F X X 
2 31 M X X 
3 32 F 
 
X 
4 33 M  X 
5 39 F X X 
6 41 F  X 
7 42 F  X 
8 43 F 
 
X 
9 44 F X X 
10 44 F X X 
11 45 F 
 
X 
12 47 F X X 
13 48 F X X 
14 49 F X X 
15 49 M X X 
16 51 M X X 
17 51 M X X 
18 52 M X X 
19 53 F  X 
20 53 M X X 
21 53 M X X 
22 54 F X X 
23 55 F X X 
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24 56 F X X 
25 57 M 
 
X 
26 61 M X X 
27 61 M X X 
28 65 M 
 
X 
29 67 F X X 
30 70 M  X 
31 74 M X X 
32 74 M X X 
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Supplemental Table 3. Primer sequences used for RT-qPCR analyses.  
 
  
Primer Sequence 
IL1A Ft: AGCATGGTGGTAGTAGCAACCA 
Bt: BTTGGCTTAAACTCAACCGTCTCT 
IL6 Ft: AATTCGGTACATCCTCGACGG 
Bt: GGTTGTTTTCTGCCAGTGCCT 
CXCL1 Ft: CCCCAAGAACATCCAAAGTGTG 
Bt: GCAGGATTGAGGCAAGCTTTC 
CXCL2 Ft: TCATCGAAAAGATGCTGAAAAATG 
Bt: GAACAGCCACCAATAAGCTTCCT 
CXCL3 Ft: GCATCCCCCATGGTTCAG 
Bt: TCAGTTGGTGCTCCCCTTGT 
CCL2 Ft: AAGATCTCAGTGCAGAGGCTCG 
Bt: CACAGATCTCCTTGGCCACAA 
TNF Ft: TGGCCCAGGCAGTCAGA 
Bt: GGTTTGCTACAACATGGGCTACA 
CCL8 Ft: CTCATGGCAGCCACTTTCAG 
Bt: GCAGGTGATTGGAATGGAAACT 
IL36G Ft: GGGTCAGAACCTTGTGGCAG 
Bt: TAGCTGCAATGTCGGCTGTT 
IL2 Ft: AAGAATCCCAAACTCACCAGGAT 
Bt: TAGACACTGAAGCTGTTTCAGTTCTG 
IFNG Ft: ACTCATCCAAGTGATGGCTGAA 
Bt: AACAGCATCTGACTCCTTTTTCG 
ADRB2 Ft: CGCTTCCATGTCGAACCT 
Bt: TCTTGAGGGCTTTGTGCTCC 
ACOX1 Ft: TGCTTTGGTTGATGCATTTGA 
Bt: CATAGCGGCCAAGCACAGA 
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Supplemental Table 4. List of top 50 most upregulated and top 50 most down-regulated 
genes when comparing pre-activated CD8+ Tcm with overnight NE treatment. The log 
ratio differences were used to rank the genes. Genes are listed in alphabetical order. 
Gene symbol Gene name Ratio 
(WT/NE) 
p-
value 
HBB hemoglobin, beta  -0.96 0.03 
C8orf29 AGENCOURT_7912774 NIH_MGC_72 cDNA 
clone  
-0.80 0.04 
FAM104B family with sequence similarity 104, member B  -0.79 0.03 
TLR8 toll-like receptor 8  -0.78 0.06 
CXCL2 chemokine (C-X-C motif) ligand 2 -0.77 0.22 
DNASE1L3 deoxyribonuclease I-like 3  -0.76 0.04 
ARPP21 cAMP-regulated phosphoprotein, 21kDa -0.72 0.01 
FAM186B family with sequence similarity 186, member B  -0.70 0.07 
FAM43B family with sequence similarity 43, member B  -0.70 0.00 
FLJ31485 uncharacterized LOC440119  -0.69 0.09 
HOXB7 homeobox B7  -0.69 0.08 
PRKACB protein kinase, cAMP-dependent, catalytic, beta  -0.68 0.00 
RAMP3 receptor (G protein-coupled) activity modifying 
protein 3  
-0.66 0.09 
GAL3ST4 galactose-3-O-sulfotransferase 4  -0.66 0.01 
GPR17 G protein-coupled receptor 17  -0.63 0.10 
SLC22A7 solute carrier family 22 (organic anion 
transporter), member 7  
-0.63 0.05 
KLHL14 kelch-like 14 (Drosophila)  -0.63 0.01 
PLA2G4D phospholipase A2, group IVD (cytosolic) -0.62 0.09 
KIAA1875 KIAA1875 -0.62 0.01 
TNFRSF17 tumor necrosis factor receptor superfamily, 
member 17  
-0.62 0.07 
TMEM156 transmembrane protein 156 -0.62 0.02 
TMEM231 transmembrane protein 231  -0.62 0.15 
FLJ42709 uncharacterized LOC441094  -0.60 0.11 
CXCL1 chemokine (C-X-C motif) ligand 1 -0.60 0.42 
NXNL1 nucleoredoxin-like 1  -0.60 0.05 
SERPINB2 serpin peptidase inhibitor, clade B (ovalbumin), 
member 2 
-0.60 0.10 
CYP24A1 cytochrome P450, family 24, subfamily A, 
polypeptide 1 
-0.60 0.12 
TCHH trichohyalin  -0.59 0.11 
IL1B interleukin 1, beta -0.59 0.15 
71 
 
FBN2 fibrillin 2  -0.59 0.06 
TBX10 T-box 10  -0.59 0.00 
ENO4 enolase family member 4  -0.59 0.05 
UROS uroporphyrinogen III synthase  -0.59 0.01 
TLR4 toll-like receptor 4  -0.59 0.16 
USH2A Usher syndrome 2A  -0.58 0.13 
EMR4P egf-like module containing, mucin-like, hormone 
receptor-like 4 pseudogene 
-0.58 0.07 
DKFZP761C1711 mRNA; cDNA DKFZp761C1711  -0.58 0.08 
FBN1 fibrillin 1  -0.58 0.11 
NRXN2 neurexin 2  -0.58 0.02 
DEFA3 defensin, alpha 3, neutrophil-specific  -0.57 0.22 
TSC1 tuberous sclerosis 1  -0.57 0.05 
PCDH7 protocadherin 7  -0.57 0.03 
PAGE1 P antigen family, member 1 -0.57 0.08 
TFAP2A transcription factor AP-2 alpha  -0.56 0.03 
SNORA14A small nucleolar RNA, H/ACA box 14A  -0.56 0.03 
FLJ43663 uncharacterized LOC378805 -0.56 0.06 
GREM1 gremlin 1  -0.55 0.09 
HERC2P4 hect domain and RLD 2 pseudogene 4 -0.55 0.01 
TRPM4 transient receptor potential cation channel, 
subfamily M, member 4  
-0.55 0.12 
SEMA3F sema domain, immunoglobulin domain (Ig), short 
basic domain, secreted 
-0.54 0.06 
AFAP1L2 actin filament associated protein 1-like 2  0.97 0.00 
CDADC1 cytidine and dCMP deaminase domain contain 1 0.47 0.00 
GXYLT2 glucoside xylosyltransferase 2 0.48 0.02 
C15orf41 chromosome 15 open reading frame 41  0.48 0.00 
TMC8 transmembrane channel-like 8  0.48 0.04 
CCDC112 coiled-coil domain containing 112 0.48 0.01 
SIRPG signal-regulatory protein gamma 0.48 0.05 
OAS1 2'-5'-oligoadenylate synthetase 1, 40/46kDa 0.49 0.00 
SEC24A SEC24 family, member A (S. cerevisiae) 0.49 0.02 
GCNT1 glucosaminyl (N-acetyl) transferase 1, core 2  0.49 0.01 
YES1 v-yes-1 Yamaguchi sarcoma viral oncogene 
homolog 1  
0.49 0.00 
MAP7 microtubule-associated protein 7  0.49 0.01 
NOG noggin  0.50 0.05 
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TMPO thymopoietin 0.50 0.02 
NRTN neurturin 0.50 0.02 
TIMD4 T-cell immunoglobulin and mucin domain 
containing 4  
0.50 0.04 
CCL27 chemokine (C-C motif) ligand 27 0.51 0.00 
HYDIN2 hydrocephalus inducing homolog 2 0.53 0.02 
GGT8P gamma-glutamyltransferase 8 pseudogene 0.54 0.00 
CXCR7 chemokine (C-X-C motif) receptor 7  0.54 0.00 
IFI44 interferon-induced protein 44  0.54 0.00 
SUGT1P3 suppressor of G2 allele of SKP1 (S. cerevisiae) 
pseudogene 3  
0.54 0.05 
IKBKE inhibitor of kappa light polypeptide gene 
enhancer in B-cells, kinase epsilon  
0.55 0.01 
OIP5 Opa interacting protein 5 0.56 0.05 
ZDHHC21 zinc finger, DHHC-type containing 21 0.56 0.00 
Q5D1D6 Q5D1D6_CERAE, Guanylate binding protein 1 0.56 0.05 
C14orf102 chromosome 14 open reading frame 102 0.56 0.00 
PRKCE protein kinase C, epsilon 0.57 0.01 
SLCO4C1 solute carrier organic anion transporter family, 
member 4C1  
0.58 0.01 
ELOVL7 ELOVL fatty acid elongase 7  0.59 0.01 
IL20RA interleukin 20 receptor, alpha  0.60 0.04 
FGFBP2 fibroblast growth factor binding protein 2  0.61 0.03 
SERPINE1 serpin peptidase inhibitor, clade E (nexin, 
plasminogen activator inhibitor type 1), member 1  
0.62 0.01 
MTSS1 metastasis suppressor 1  0.62 0.01 
C15orf37 chromosome 15 open reading frame 37  0.63 0.00 
GZMB granzyme B (granzyme 2, cytotoxic T-
lymphocyte-associated serine esterase 1) 
0.65 0.02 
TTC16 tetratricopeptide repeat domain 16  0.66 0.01 
CMPK2 cytidine monophosphate (UMP-CMP) kinase 2, 
mitochondrial  
0.66 0.03 
DCD dermcidin  0.67 0.03 
RSAD2 radical S-adenosyl methionine domain contain 2 0.67 0.05 
PTPN3 protein tyrosine phosphatase, non-receptor type 
3 
0.67 0.04 
CD244 CD244 molecule, natural killer cell receptor 2B4  0.69 0.01 
PLLP plasmolipin  0.70 0.00 
HPS4 Hermansky-Pudlak syndrome 4 0.72 0.00 
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FCGR3A Fc fragment of IgG, low affinity IIIa, receptor  0.73 0.03 
IFI44L interferon-induced protein 44-like 0.76 0.00 
UBL4A ubiquitin-like 4A  0.80 0.00 
PROK2 prokineticin 2  0.80 0.04 
N4BP3 NEDD4 binding protein 3  0.81 0.00 
MYL2 myosin, light chain 2, regulatory, cardiac, slow  0.84 0.03 
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Supplemental Table 5. List of top 50 most upregulated and top 50 most down-regulated 
genes when comparing 24h and 72h post-activated CD8+ Tcm with overnight NE 
treatment. The maximum of either the log ratio of the 24h and 72h comparisons were 
used to rank the genes.  
Gene 
symbol 
Gene name Ratio 24h 
(WT/NE) 
p-value 
(24h) 
Ratio 72h 
(WT/NE) 
p-
value 
(72h) 
PSPHP1 phosphoserine 
phosphatase 
pseudogene 1 
-1.33 0.00 -0.906 0.082 
CXCL2 chemokine (C-X-C 
motif) ligand 2  
-1.12 0.07 -1.128 0.143 
CSF3 colony stimulating 
factor 3, granulocyte  
-1.12 0.00 -0.427 0.219 
CXCL3 chemokine (C-X-C 
motif) ligand 3  
-0.86 0.13 -0.957 0.173 
ANK3 ankyrin 3, node of 
Ranvier 
-0.82 0.00 0.031 0.919 
CDH1 cadherin 1, type 1, E-
cadherin  
-0.80 0.04 -0.636 0.185 
IL36G interleukin 36, gamma -0.79 0.01 -0.771 0.032 
SNORD98 small nucleolar RNA, 
C/D box 98 
-0.76 0.00 -0.119 0.669 
CXCL1 chemokine (C-X-C 
motif) ligand 1  
-0.76 0.31 -1.398 0.124 
LUZP1 leucine zipper protein 1 -0.69 0.05 -0.050 0.908 
HEATR1 HEAT repeat 
containing 1  
-0.68 0.00 -0.041 0.862 
ARNTL aryl hydrocarbon 
receptor nuclear 
translocator-like 
-0.67 0.00 -0.506 0.050 
B3GAT2 beta-1,3-
glucuronyltransferase 2  
-0.67 0.00 -0.211 0.421 
GABRB3 gamma-aminobutyric 
acid  
-0.67 0.00 -0.115 0.638 
SNORD114-
3 
small nucleolar RNA, 
C/D box 114-3  
-0.66 0.01 -0.086 0.789 
TRIM62 tripartite motif 
containing 62  
-0.66 0.00 -0.207 0.452 
IL4 interleukin 4 -0.66 0.01 0.043 0.885 
RAB19 RAB19, member RAS 
oncogene family 
-0.66 0.00 -0.008 0.972 
CRHR1 corticotropin releasing 
hormone receptor 1  
-0.65 0.01 -0.076 0.793 
TNFAIP6 tumor necrosis factor, 
alpha-induced protein 
6 
-0.64 0.03 -0.689 0.059 
USP45 ubiquitin specific 
peptidase 45 
-0.64 0.00 -0.211 0.423 
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SHANK1 SH3 and multiple 
ankyrin repeat domains 
1 
-0.64 0.03 -0.086 0.812 
HAS3 hyaluronan synthase 3 -0.64 0.02 -0.080 0.813 
WDR33 WD repeat domain 33  -0.64 0.03 -0.056 0.877 
IL28RA interleukin 28 receptor, 
alpha (interferon, 
lambda receptor) 
-0.63 0.00 -0.125 0.626 
FLJ40536 cDNA FLJ40536 fis, 
clone TESTI2047930 
-0.63 0.00 -0.110 0.686 
PFN1P2 profilin 1 pseudogene 
2  
-0.62 0.01 -0.050 0.871 
GZF1 GDNF-inducible zinc 
finger protein 1 
-0.60 0.07 -0.152 0.705 
GPR15 G protein-coupled 
receptor 15  
-0.60 0.03 -0.326 0.350 
SLC4A5 solute carrier family 4, 
sodium bicarbonate 
cotransporter, member 
5 
-0.60 0.04 -0.178 0.620 
AMICA1 cDNA FLJ33028 fis, 
clone THYMU2000140 
-0.59 0.01 0.002 0.995 
SNORD66 small nucleolar RNA, 
C/D box 66  
-0.59 0.00 -0.076 0.724 
ALDOAP2 Human aldolase 
pseudogene 
-0.58 0.01 -0.427 0.130 
C17orf105 chromosome 17 open 
reading frame 105  
-0.58 0.01 -0.218 0.450 
OR1N2 olfactory receptor, 
family 1, subfamily N, 
member 2 
-0.57 0.02 -0.012 0.967 
Q07610 Q07610_RAT -0.57 0.03 -0.466 0.135 
ACP1 acid phosphatase 1, 
soluble 
-0.56 0.01 -0.195 0.458 
FLJ42351 uncharacterized 
LOC400999 
-0.56 0.01 -0.126 0.644 
KIAA1486 KIAA1486  -0.56 0.02 0.038 0.900 
TMSB4Y thymosin beta 4, Y-
linked  
-0.56 0.01 -0.737 0.004 
SNX29 sorting nexin 29  -0.55 0.01 -0.243 0.370 
TTC23L tetratricopeptide repeat 
domain 23-like 
-0.55 0.04 -0.235 0.482 
ARAP1 ArfGAP with RhoGAP 
domain, ankyrin repeat 
and PH domain 1 
-0.55 0.01 0.002 0.993 
ANKRD43 ankyrin repeat domain 
43  
-0.55 0.01 -0.076 0.779 
RHBDL3 rhomboid, veinlet-like 3 -0.55 0.01 -0.252 0.344 
SCD5 stearoyl-CoA 
desaturase 5 
-0.55 0.02 -0.101 0.735 
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C21orf15 CU015_HUMAN -0.54 0.01 0.013 0.961 
FSIP2 fibrous sheath 
interacting protein 2  
-0.54 0.05 -0.138 0.687 
TTC16 tetratricopeptide repeat 
domain 16 
-0.54 0.03 -0.226 0.446 
SNORA22 DKFZp686E1139_r1 
686  
-0.54 0.01 -0.227 0.387 
HOXB9 homeobox B9 0.52 0.00 0.302 0.034 
IL26 interleukin 26 0.51 0.02 -0.011 0.966 
GPR124 G protein-coupled 
receptor 124 
0.52 0.03 0.256 0.394 
NFAM1 NFAT activating 
protein with ITAM motif 
1 
0.52 0.04 0.012 0.970 
CALCA calcitonin-related 
polypeptide alpha 
0.53 0.08 0.345 0.345 
KIF7 kinesin family member 
7  
0.53 0.01 0.085 0.742 
TUBB6 tubulin, beta 6 class V  0.53 0.01 0.261 0.280 
ULBP1 UL16 binding protein 1 0.54 0.01 0.438 0.069 
ITGAD integrin, alpha D  0.54 0.06 0.015 0.967 
CHD5 chromodomain 
helicase DNA binding 
protein 5  
0.55 0.06 0.232 0.522 
OIP5 Opa interacting protein 
5 
0.55 0.06 0.044 0.901 
RBFOX2 RNA binding protein, 
fox-1 homolog  
0.55 0.11 0.873 0.037 
BTLA B and T lymphocyte 
associated 
0.56 0.07 0.290 0.449 
PGBD1 piggyBac transposable 
element derived 1  
0.57 0.01 0.307 0.257 
SCHIP1 schwannomin 
interacting protein 1 
0.58 0.04 0.307 0.362 
DIXDC1 DIX domain containing 
1  
0.58 0.02 0.105 0.739 
GPR133 G protein-coupled 
receptor 133  
0.58 0.02 0.282 0.363 
IL23R interleukin 23 receptor 0.59 0.01 0.053 0.854 
NEXN-AS1 chromosome 1 open 
reading frame 118 
0.60 0.01 0.070 0.796 
C10orf92 chromosome 10 open 
reading frame 92  
0.60 0.00 0.073 0.712 
GDF10 growth differentiation 
factor 10 
0.60 0.01 0.230 0.430 
CD38 CD38 molecule  0.60 0.02 0.127 0.694 
RPL37A BROAD Institute 
lincRNA 
0.61 0.00 0.301 0.251 
CCNA2 cyclin A2 0.61 0.08 0.042 0.922 
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CCL4 chemokine (C-C motif) 
ligand 4 
0.61 0.01 0.063 0.826 
ZNF788 zinc finger family 
member 788 
0.62 0.05 0.272 0.476 
TK1 thymidine kinase 1, 
soluble 
0.62 0.01 0.034 0.910 
CHAC1 ChaC, cation transport 
regulator homolog 1 
(E. coli) 
0.63 0.06 0.472 0.247 
BCAT1 branched chain amino-
acid transaminase 1, 
cytosolic 
0.63 0.01 -0.007 0.982 
ECSCR endothelial cell-specific 
chemotaxis regulator 
0.64 0.05 0.160 0.686 
DGKI diacylglycerol kinase,  0.65 0.05 0.508 0.218 
ZNF365 zinc finger protein 365  0.65 0.02 0.218 0.516 
CCL3L3 chemokine (C-C motif) 
ligand 3-like 3 
0.66 0.05 0.271 0.515 
C10orf105 chromosome 10 open 
reading frame 105 
0.66 0.03 0.452 0.214 
CTH cystathionase 
(cystathionine gamma-
lyase)  
0.68 0.01 0.532 0.121 
ABLIM3 actin binding LIM 
protein family, member 
3 
0.68 0.05 0.441 0.304 
CKAP2L cytoskeleton 
associated protein 2-
like  
0.70 0.03 0.059 0.885 
CD200 CD200 molecule  0.71 0.02 0.453 0.217 
DNAJC12 DnaJ (Hsp40) 
homolog, subfamily C, 
member 12 
0.71 0.04 0.381 0.373 
SPC24 SPC24, kinetochore 
complex component, 
homolog  
0.71 0.06 0.003 0.995 
IL2 interleukin 2 0.72 0.11 0.472 0.391 
GPT2 glutamic pyruvate 
transaminase 
0.72 0.07 0.116 0.811 
NEIL3 nei endonuclease VIII-
like 3 (E. coli)  
0.73 0.03 0.000 1.000 
CCL3 chemokine (C-C motif) 
ligand 3 
0.74 0.03 0.168 0.679 
G0S2 G0/G1switch 2 0.75 0.01 0.127 0.710 
NUMB BROAD Institute 
lincRNA  
0.76 0.00 0.300 0.330 
MYOF myoferlin  0.81 0.07 0.374 0.486 
ESCO2 establishment of 
cohesion 1 homolog 2 
0.81 0.07 0.046 0.933 
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NHS Nance-Horan 
syndrome (congenital 
cataracts and dental 
anomalies) 
0.85 0.01 0.391 0.331 
SHC4 SHC  family, member 4 1.08 0.00 0.397 0.369 
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Figure S1. Gating strategy for ADRB2 staining on CD8 T cell subsets. 
 
               
 
 
Gating strategy for ADRB2 staining on CD8 T cell subsets is illustrated. We first gated 
on live lymphocytes based on the FSC and SSC, followed by CD8+ T cells (APC), and 
then gated on the subsets: naïve (CD45RA+, PE), (CD62L+, FITC), central memory 
(CD45RA-/CD62L+) and effector memory (CD45RA-/CD62L-). Finally, we gated on 
ADRB2 (PerCP/Cy5.5) positive cells within each CD8 T cell subset. 
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Figure S2. ADRB2 expression in individuals with high and low levels of NE in their 
serum. 
 
ADRB2 expression in individuals with high and low levels of NE in their serum. ADRB2 
expression in individuals with high levels of norepinephrine (>150pg/ml, N=17) 
compared to individuals with low levels of norepinephrine (<150pg/ml, N=15). There 
were no significant differences in the percentage or MFI of ADRB2 expressed CD8 T 
cell subsets (Tn, Tm) between individuals with high or low levels of NE on a population 
or individual cell level. 
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Abstract  
 
Objective: Previous studies have shown the detrimental impact of caregiving stress on different 
types of immune cells. This study examines the effects of caregiving for hematopoietic stem cell 
transplant recipients on the immune phenotype and the function of CD8 T cell subsets (naïve and 
memory). 
Methods: We examine twenty-one caregivers’ and twenty age-, gender- and ethnicity-matched 
controls’ immune cell composition as well as naïve (defined by CD45RA+CD28+) and memory 
(CD45RA-CD28+/-) CD8+ T cell cytokine gene and protein expression by RT-qPCR and flow 
cytometry.  
Results: Caregivers of transplant patients showed an increase in gene expression of pro-
inflammatory cytokines (TNF, CXCL1, IL1A) and a decrease in growth-related cytokines (IL2, 
IFNG) by CD8 Tm cells compared to matched controls.  
Conclusions: Our results demonstrate memory CD8 are susceptible to the effects of caregiving 
stress by inducing a pro-inflammatory state while simultaneously inhibiting memory CD8 function 
by reducing proliferation-related cytokines. This data suggests that the stress of caregiving may 
have a detrimental impact on an individual’s ability to respond to previous antigenic challenges 
and fight off infections.    
Words: hematopoietic stem cell transplant caregivers, family caregivers, CD8 T cells, caregiving 
stress 
Abbreviations: IL = interleukin; PBMC = peripheral mononuclear cells; HSCT = hematopoietic 
stem cell transplant; Tn = CD8 naïve T cell; Tm = CD8 memory T cell  
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Introduction 
 
Chronic stressors are commonplace and challenge our psychological, behavioral and 
physiological health. Recent evidence has shown the detrimental impact of chronic stress on 
human health, including immune health outcomes. Chronic stress-induced biological changes in 
the immune system reveal the inhibited function of cytokines, decreased lymphocyte counts, and 
decreased immune cell proliferation and functionality; furthermore, these biological changes in 
immune function can lead to increased infection rates, impaired responses to vaccines, pre-
mature aged immune system, or dysregulation in the inflammatory response (Cohen et al., 
1999;Gouin et al., 2008;Kiecolt-Glaser et al., 1996;Kiecolt-Glaser et al., 2003;Padgett et al., 
2003).  
Several human studies examining the effects of chronic stress on immune health have 
resulted in conflicting findings or observed no differences between the chronically stressed 
individual and their control (Bonneau et al., 1990;Gouin et al., 2008;Hu et al., 2014;Padgett et al., 
2003). A majority of these studies have examined immune cell changes in whole blood or 
peripheral mononuclear cells (PBMCs)(Bauer, Vedhara, Perks, Wilcock, Lightman, and Shanks, 
2000;Bonneau et al., 1990;Castle et al., 1995;Dhabhar et al., 2012;Glaser et al., 1998;Gouin et 
al., 2008;Mills et al., 1997;Vitaliano et al., 1998)(Bauer, Vedhara, Perks, Wilcock, Lightman, and 
Shanks, 2000;Bonneau et al., 1990;Castle et al., 1995;Dhabhar et al., 2012;Glaser et al., 
1998;Gouin et al., 2008;Mills et al., 1997;Vitaliano et al., 1998) (Mills et al., 1997; Bauer et al., 
2000; Glaser et al., 1998; Bonneau et al., 1990; Vitaliano et al., 1998); it is unknown if chronic 
psychological stress impacts CD8 T cell subsets in a homogeneous manner. Isolation of specific 
immune cell subsets may reveal differences induced by chronic stress that may otherwise be 
masked by a mixture of immune cells in whole blood; thus, recent studies have focused on 
specific immune cells subsets such as CD4 T cells, natural killer (NK) cells or B cells (Bauer et 
al., 2000;Bonneau et al., 1990;Castle et al., 1995;Dhabhar et al., 2012;Glaser et al., 1998;Gouin 
et al., 2008;Mills et al., 1997;Vitaliano et al., 1998). Less work has focused on the effects of 
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chronic stress on CD8 T cells despite their critical role in mounting an effective adaptive immune 
response (Araki et al., 2008;Araki et al., 2009;Fann et al., 2006). CD8 T cells are cytotoxic to 
infected cells and are comprised of two major subsets: naïve (Tn), which have not yet 
encountered an antigenic challenge, and memory (Tm) that have already been exposed to an 
antigen and can respond more rapidly.  
Family caregivers serve as an ideal clinical model to study the effects of chronic stress on 
immune cell function since they often perceive their role as stressful, function in their role for 
several years, and have impaired health outcomes, including impaired immunity (Bauer et al., 
2000;Castle et al., 1995;Futterman et al., 1996;Gouin et al., 2008;Rohleder et al., 2009;Schulz et 
al., 1999;Vedhara et al., 2002;Vitaliano et al., 2003). A majority of the research on the biological 
impact of caregiving has focused on caregivers of dementia and Alzheimer’s and cancer patients, 
or older adult caregivers. This research has shown a wide-range of effects on immune health 
including altered cytokine production, immune cell dysfunction, decreased immune cell 
proliferation and inhibited responses to vaccination (Glaser et al., 1998;Gouin et al., 2008;Kiecolt-
Glaser et al., 1996;Lutgendorf and Laudenslager, 2009;Mills, Yu, Ziegler, Patterson, and Grant, 
1999;Vitaliano et al., 2003).  
Family caregivers of hematopoietic stem cell transplant (HSCT) recipients are an 
understudied population of caregivers; they often serve in their role for several years and 
accompany the HSCT patient through one of the most intense treatments available for cancer 
patients that can result in multiple physical, psychological and social challenges for the HSCT 
caregiver (Beattie et al., 2011;Eldredge, Nail, Maziarz, Hansen, Ewing, and Archbold, 
2006;Futterman et al., 1996;Laudenslager, 2014;Rizzo et al., 1999). This study aimed to 
determine whether there is a difference between HSCT caregivers and non-caregivers in terms of 
their adaptive immune cell composition as well as the transcription and translation of pro-
inflammatory (IL1A, IL2, IL6, IL8) and growth-related cytokines (IL2, IFNG) and chemokines 
(CCL2, CCL8, CXCL1) of CD8 T cell subsets (Tn and Tm) compared to non-caregivers.  
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Methods 
Human subjects and blood collection 
 
Participants for this study (N=41) were drawn from a larger longitudinal study examining 
physiological and clinical markers of chronic stress in caregivers of HSCT recipients (Bevans 
under review) at the National Institutes of Health (NIH) Clinical Center.  Blood was drawn from the 
participants at 3 time points: up to 2 weeks before transplantation, one week after transplantation 
and 6 weeks post-discharge. Blood samples collected at the 3 time points of the primary study 
were combined for this study in order to have an adequate cell number for experimental use. 
PBMCs were isolated from the peripheral blood of adult caregivers (N=21), and age-, gender- 
and ethnicity-matched non-caregiver controls (N=20) and frozen at -80°C for use in this study. 
Utilization of these samples and the primary investigation was approved by the Internal Review 
Boards at the National Heart Lung and Blood Institute (NHLBI), NIH and the University of 
Pennsylvania. 
Flow cytometry for phenotype and intracellular cytokine analyses 
 
PBMCs were stained for phenotyping and intracellular cytokines for flow cytometry 
analysis with the Canto II Flow Cytometer (BD Biosciences). Antibodies included: Viability (e506), 
CD8 (PeCy7, Biolegend), CD4 (Pacific Blue, Biolegend), CD3 (ApcCy7, Biolegend), CD28 (APC, 
Biolegend), CD45RA (FITC, Biolegend).  
For intracellular cytokine staining, frozen PBMCs were thawed and incubated for 3 hours 
at 5% O2. Next, PMA (50ng/mL, Sigma), Ionomycin (80ng/mL, Sigma), and a Golgi Block (1 
µg/million cells, BD Biosciences) were added to the cells and incubated for 4 hours at 5% O2.  
Cells were washed and fixation buffer added then incubated overnight at 4°C in the dark. The 
next day, cells were washed with permealization buffer and then antibodies added for intracellular 
staining for IL1-α (PE, Biolegend), TNF (PercpCy5.5, Biolegend), IL-2 (PercpCy5.5, Biolegend), 
and CCL-2 (PE, eBioscience). Isotype and fluorescent dye matched non-specific mouse IgG was 
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used as controls for cytokine staining. Samples were collected on the Canto II Flow Cytometer 
(BD Biosciences). Data and mean fluorescent intensity were further analyzed using FloJo V10 
software. 
Isolation and culture of human CD8 T cell subsets  
 
For isolation of naïve and memory CD8 T cells from frozen PBMCS of caregivers and 
non-caregivers, PBMCs were thawed in a 37°C water bath, washed and resuspended in RPMI. 
Naïve and memory CD8 T cells were isolated by cell sorter (MoFlo, Dako Cytomation) using the 
following staining: Viability (e506), CD8+, naive (CD45RA+, CD28+), and memory (CD28+ -). The 
purity of sorted naïve and memory CD8 T cells was >96%. 
Isolated CD8 T cell subsets were either used for gene expression analysis immediately or 
incubated at 5% O2 with anti-CD3/28-coupled beads at a cell:bead ratio of 1:1 in RPMI1640 with 
10% FBS and penicillin (10U/ml)/streptomycin (10µg/ml) and harvested at 24 hours for analyses 
of mRNA.  
Quantitative RT-qPCR of mRNA  
 
The procedure for quantitative RT-PCR (RT-qPCR) was described previously (Araki et 
al., 2009). Briefly, RNA was isolated with the RNeasy Mini Kit for Qiacube (Qiagen) and cDNA 
was synthesized with oligo-DT and random hexamers (Invitrogen) with 60ng of RNA. The mRNA 
levels were determined by RT-qPCR using 2x SYBR Green PCR Master Mix (Applied 
Biosystems) and normalized to a lymphocyte housekeeping gene, acyl-Coenzyme A oxidase 1 
(ACOX1), as described previously (Araki et al., 2009). RT-qPCR was conducted for gene 
expression analysis of several cytokines and chemokines important to CD8 T cell function and 
related to inflammatory processes, including: IL2, CCL2, CXCL1, IL6, IL8, IFN-G, IL1A, CCL8 and 
TNF. The value of cytokine mRNA threshold cycle (Ct) was normalized to ACOX1. PCR was 
performed on 7900HT Fast Real-Time PCR System (Applied Biosystems).  
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Statistics 
 
Analyses were conducted comparing the HSCT caregiver group with the non-caregiver 
control group on immune cell composition, intracellular proteins and gene expression levels. 
Since this study controlled for covariates such as age, gender and ethnicity, no correlational 
statistics were conducted. Data are expressed as the mean ± SEM and we considered p < 0.05 
as statistically significant. 
Results 
T lymphocyte composition is similar between controls and HSCT caregivers 
 
First, an examination of potential phenotype changes in HSCT caregivers (N=21) 
compared to controls (N=20) was conducted by examining the composition of adaptive immune 
cells in PBMC. To address this, flow cytometry analysis was utilized with antibodies staining for 
various immune cell populations as illustrated by the gating strategy (Fig. 1A). Table 1 shows the 
immune cell composition percentages between caregivers and their controls. There was no 
significant difference between caregivers and controls in their adaptive immune cell composition 
(Fig. 1B). T lymphocyte composition was not significantly different between the HSCT caregivers 
and controls, however CD8 Tm cells were trending (p<0.06) toward a descriptively higher 
percentage in controls compared to the HSCT caregivers (Table 1).  
 
Table 1. Immune cell composition between controls and family caregivers 
Lymphocytes T cells CD8 T cells Tn Tm CD4 T cells 
Control 62.9% 75.9% 18.0% 41.1% 40.0% 41.7% 
Caregiver 60.4% 73.9% 16.6% 44.3% 33.1% 46.9% 
 
Increased expression and intracellular cytokine proteins of pro-inflammatory cytokines 
and chemokines in caregivers compared to controls 
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While no changes were found at the cellular level in terms of immune cell composition 
between caregivers and controls, this study next asked whether the function of these immune 
cells might be altered in our chronically stressed population. From the 41 participants (caregivers 
N=21, controls N=20), 22 participant samples (caregivers N=13, controls N=9) were successfully 
isolated for the mRNA analyses. The results showed caregivers had significantly higher 
expression of pro-inflammatory cytokines including CXCL1 at baseline and TNF at 24 hours, and 
a lower expression of proliferation and growth related genes including IL2 at baseline and IFN-G 
at 24 hours in CD8 Tm cells (Fig. 2A).  
This study next examined if changes at the gene level in family caregivers (N=21) 
compared to controls (N=20) were translated to the protein level by studying four intracellular 
proteins using flow cytometry. TNF levels were significantly increased in CD8 Tm cells which 
correlated with the increase in gene expression changes (Fig. 2B). There was no difference 
between controls and caregivers in the other cytokines (CXCL1, IFN-γ, IL-2) measured despite 
the changes seen at the mRNA level.  
Discussion 
 
 This study examined the T lymphocyte composition, cytokine gene expression and 
intracellular proteins of CD8 T cell subsets (naïve and memory) in HSCT family caregivers and 
non-caregivers. There was no significant difference in immune cell composition of caregivers 
compared to controls, which was similar to findings in other studies of HSCT caregivers 
(Laudenslager, 2014), suggesting chronic stress does not significantly impact immune cell 
composition. However, the gene expression of certain cytokines and chemokines of CD8 Tm cells 
differed between groups: HSCT caregivers had increased expression of pro-inflammatory 
cytokines TNF and CXCL1 and decreased expression of activation induced proliferative cytokines 
IL2 and IFN-G. Intracellular TNF proteins were also significantly increased in CD8 Tm cells. This 
study concurs with the results of previous investigations in other immune cell types which 
examined caregivers and matched control subjects to find caregivers’ illnesses lasted longer, they 
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had lower levels of IL-2 and IL-1β in CD4 Th1 associated cytokines as well as an increase in IL-6 
(Kiecolt-Glaser et al., 1987;Kiecolt-Glaser et al., 1995;Kiecolt-Glaser et al., 2003). It appears that 
the chronic stress of caregiving impacts memory CD8 T cells more significantly than other cell 
types. Inhibited function of memory CD8 T cells presents a clinical challenge for individuals since 
they will be more compromised in fighting off recall infections rather than new immune 
challenges; this is especially important for elderly caregivers since aging is associated with an 
increased percentage and number of memory cells compared to naïve cells.   
 Caregivers of HSCT patients present a unique perspective on caregiving since their 
burden is typically shorter but more intense and patients have a better prognosis compared to 
caregivers of the more studied populations such as Alzheimer’s (Laudenslager, 2014). In 
summary, our study shows HSCT caregivers exhibit a pro-inflammatory response and growth-
related inhibitory response in CD8 Tm cells compared to non-caregivers, possibly contributing to 
an immunocompromised status for opportunistic infections that would typically be addressed by 
memory T cells. This study is unique since it is the first to examine the effects of HSCT caregiving 
on CD8 T cell subsets’ transcription and translation of important inflammatory and growth-related 
cytokines and chemokines. There were a few limitations to this study; since this study was based 
off a primary investigation examining physiological changes in HSCT caregivers and their 
controls, we were limited by the original sample size and measures. In addition, given small 
amount of blood collected, we were limited in the number of analyses we could conduct for the 
gene expression and intracellular protein analyses.  
Future work should address the possible mechanisms behind these changes in 
caregivers’ CD8 Tm cells and isolate this subset over the pre, transplantation, and post-
transplantation periods; previous studies have reported caregiver distress is highest pre-
transplantation and decreases over time (Beattie et al., 2011). This work is important to uncover 
the transcriptional and phenotypic changes that occur in caregivers despite the challenges of 
conducting these types of studies including: caregiver recruitment, attrition, collection of large 
volumes of blood for future isolation of immune subsets, and challenge of conducting longitudinal 
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studies. In general, our findings are consistent with prior studies showing the deficits in immune 
function of family caregivers and other chronically stressed populations, and suggest the 
importance of identifying specific immune subsets when examining stress-induced immunological 
changes.  
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Figure 1. Adaptive immune cell composition is similar between controls and HSCT 
caregivers (A) A representative staining of PBMCs of controls and HSCT caregivers by flow 
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cytometry. Cells were gated first on lymphocytes followed by single cells, live cells, T cells, CD4 
and CD8 T cells, and CD8 T cell subsets: naïve (Tn) and memory (Tm). (B) Comparison of 
immunophenotype of non-caregivers (N=20) and caregivers (N=21) included: lymphocytes, T 
cells, CD4 T cells, CD8 T cells, and naïve and memory CD8 T cells. Data illustrated as the 
percentage of the immune cell population in non-caregivers and caregivers. Results throughout 
the manuscript are presented as the mean ± SEM. * p < 0.05 was considered significant. 
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Figure 2. Caregivers show an increased pro-inflammatory gene expression and decreased 
proliferative related gene expression compared to controls (A) Gene expression changes in 
family caregivers (N=9-13) compared to their age- and gender-matched controls (N=7-9). Results 
are presented as the relative expression in LOG10. (B) Intracellular level of TNF in CD8 Tm cells 
between controls (N=20) and caregivers (N=15). Data is presented as the percentage TNF in 
CD8 Tm cells.  
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CHAPTER 5 
 
Overview 
 
 Provided is a summary of the study design and overall results for each article (Chapter 2, 
Chapter 3 and Chapter 4). Following this is a discussion of the major findings from this 
dissertation, including comparisons with relevant literature. Finally, provided is a discussion of the 
important areas for future research based on the findings.  
Summary 
 
 This dissertation was a translational study from ‘bench to bedside,’ utilizing in vitro and in 
vivo models in order to explore the impact of stress via norepinephrine or caregiving on human 
CD8 T cell subsets (naïve, central memory and effector memory). We focused on the expression 
of the norepinephrine receptor (beta-2 adrenergic receptor) on CD8 T cell subsets, changes in 
cytokine and chemokine gene expression and protein level expression in each subset, and 
changes in proliferation. We utilized blood samples from apheresis donors at the National 
Institute on Aging (NIA) as well as PBMCs from 41 participants (21 HSCT family caregivers, 20 
controls) of a primary investigation at the National Institutes of Health (NIH) Clinical Center.  
 Chapter 2 consisted of a comprehensive literature review exploring the literature 
regarding epigenetic regulation as a mediator of stress-induced psychological and behavioral 
factors, and immunological changes in T cell function. Results from this review support a new 
area of study for chronically stressed individuals, including family caregivers. Additionally, we 
propose a framework to examine the opportunity of incorporating epigenetic regulation as a 
mediator between psychological and behavioral factors, and T cell function in the stress 
paradigm. Finally, we offer advice for future research in this area and potential obstacles to 
consider when exploring these types of research investigations in human populations like family 
caregivers. 
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 Chapter 3 assesses the effect of NE on the functionality of different CD8 T cell subsets 
(naïve, central memory and effector memory). Results showed that memory cells (central and 
effector memory) express more beta-2 adrenergic receptors compared to naïve cells; 
consequently, memory CD8 T cells were significantly more affected by NE induced changes of 
gene expression in vitro. We also found via global gene expression analysis that NE induced an 
elevated expression of inflammatory cytokines and chemokines in resting and activated memory 
CD8 T cells, as well as reducing the expression of growth-related cytokines. Finally, we found 
individuals with high levels of NE in their serum had similar gene expression changes seen in 
vitro compared to the low NE group. 
 Chapter 4 assessed the effect of caregiving for stem cell transplant recipients on 
immunophenotype and CD8 T cell subsets (naïve and memory)-related cytokines transcription 
and translation in vivo. Results showed that caregivers showed an increase in gene expression of 
pro-inflammatory cytokines and a decrease in growth-related cytokines by memory CD8 T cells 
compared to non-caregivers.  
Major Findings 
Epigenetic regulation may serve as a mediator of stress-induced psychological and 
behavioral changes and T cell function 
 
 In this review of the literature, we examine current findings in humans supporting a 
connection between epigenetic regulation of T cell function as well as epigenetic changes 
induced by behavioral and psychological factors. We argue that epigenetic regulation may serve 
as a mediator between the psychological and behavioral changes induced by caregiving stress 
and subsequent T cell functional changes. We also considered the challenges and possibility of 
examining epigenetic regulation as a potential pathway for stress-induced immune alterations in 
the family caregiver population and presented a theoretical model illustrating the relationship 
between caregiving, behavioral and psychological factors, epigenetic regulation, and immune 
outcomes.  
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 We found significant literature currently exists in humans linking environmental stressors 
influencing psychosocial and behavioral factors that alter the epigenetic landscape (Alegria-
Torres et al., 2011;Brockie, Heinzelmann, and Gill, 2013;Essex, Boyce, Hertzman, Lam, 
Armstrong, Neumann, and Kobor, 2013); similarly, we found literature linking epigenetic 
modifications and immune cell function (Adachi and Rothenberg, 2005;Kondilis-Mangum et al., 
2013;Reiner, 2005). Many of the stress-related psychosocial and behavioral factors linked to 
epigenetic changes were also seen in family caregivers (Brockie et al., 2013;Mifsud et al., 
2011;Uddin et al., 2010). A majority of stress-induced changes in the epigenetic landscape were 
studied in early life or in utero, leaving a gap in our understanding of how stress in adulthood, like 
caregiving, can alter the epigenome (Essex et al., 2013;McGowan, Sasaki, D'Alessio, Dymov, 
Labonte, Szyf, Turecki, and Meaney, 2009;Weaver, Cervoni, Champagne, D'Alessio, Sharma, 
Seckl, Dymov, Szyf, and Meaney, 2004). This gap presents an opportunity for future research to 
make the connection between stress-induced psychosocial and behavioral changes, as well as 
immune alterations in humans.  
 This review of the literature also revealed available methodologies for epigenetic studies 
and the associated potential challenges that can be encountered in conducting this type of 
research. The literature review showed utilization of whole blood or PBMCs, which limits the 
conclusions one can draw from the source of epigenetic changes since the exact immune cell 
subset is unknown (Hunter, 2012;Jensen et al., 2012;Murgatroyd et al., 2011). Conducting large 
data analyses of epigenetic and subsequent transcriptional changes in immune cells require large 
numbers of isolated cells from patients; this poses a significant obstacle for human studies since 
participants would need to donate large quantities of blood through donation methods such as 
apheresis donation, which require time and specialized supervision by certified nursing staff. In 
addition, future studies would need to be longitudinal since epigenetic changes can be transient 
(Madrigano, Baccarelli, Mittleman, Sparrow, Vokonas, Tarantini, and Schwartz, 2012). While 
there are several obstacles to conducting human research on epigenetic changes and immune 
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function, this is a necessary pursuit since the epigenetic pathways of stress-induced alterations in 
immune function remain to be elucidated. 
 Finally, we offered a framework linking stress-induced changes in psychosocial and 
behavioral factors with immune changes by epigenetic mediation. Several theoretical models 
have been presented in the literature review as models of stress and health, but they lack the 
modern understanding of molecular mechanisms, including epigenetics as a factor controlling 
gene expression in humans and how this might play a role in stress and health outcomes (Ingram 
et al., 2005;Lutgendorf et al., 2003;McEwen, 2012). This work draws attention to the potential role 
of epigenetics as a mediator of stress-induced immune changes and the potential obstacles one 
can face in conducting human studies to better understand how stress gets ‘under the skin’ to 
alter immune outcomes in stressed populations, such as family caregivers. 
Memory CD8 T cells are more susceptible to norepinephrine than naïve cells 
 
 Chapter 3 of this dissertation explored the effects of norepinephrine (NE) on human CD8 
T cell subsets (naïve, central memory, effector memory). Results provided evidence that memory 
subsets (central and effector memory) of CD8 T cells had greater expression (~40%) for the NE 
receptor, beta-2 adrenergic receptor, than naïve cells (~10%). Furthermore, we found NE induces 
a pro-inflammatory state by increasing inflammatory cytokine production while simultaneously 
decreasing activation-induced proliferation of memory CD8 T cells. We found these changes in 
gene expression were mimicked at the protein level in memory CD8 T cell subsets. Finally, we 
showed that a high level of NE in the serum of humans was associated with an increased 
expression of inflammatory cytokines and low expression of growth-related cytokines in memory 
CD8 T cells. We were the first to report memory CD8 T cells have greater expression of the NE 
receptor and are more susceptible to the effects of NE including a pro-inflammatory status before 
and after antigenic challenge.  
 Other studies have showed the differential expression of the beta-2 adrenergic receptor 
on immune cells (Anstead et al., 1998;Bartik, Brooks, and Roszman, 1993); the majority of 
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studies have focused on CD4 and B cell expression of beta-2 adrenergic receptor while few have 
studied CD8 T cells (Kin et al., 2006;Kohm et al., 2001). Studies have also shown the link 
between chronic stress and inflammation, as mediated by neurotransmitters and hormones 
(Carlson et al., 1989;Levite, 2000;Straub et al., 1998). NE has been implicated in the 
inflammatory response in studies on CD4, NK cells and B cells in regards to specific inflammatory 
cytokines (Dhabhar et al., 2012;Dimsdale et al., 1994;Mausbach et al., 2005). Our study used a 
global gene expression analysis to examine all the possible genes influenced by NE in memory 
CD8 T cells and found several pro-inflammatory cytokines were increased, while growth-related 
cytokines were decreased. Limitation in cell number, finances, and time prevented us from 
extending the global gene expression analysis to other immune cell subsets, as well as 
conducting epigenetic studies of these cells. Future studies would benefit from our approach of 
studying isolated immune cell subsets to draw out the impact of NE on these specific cell types 
without the influence of outside variables. In addition, this study is important in showing that 
individuals may be at greater risk for previously encountered antigenic challenge-related 
infections and not new infections since memory cells were more impacted by NE than naïve cells. 
This may have a particularly important role in the elderly since memory cell populations increase 
with age while naïve cell populations decrease. 
Individuals with high levels of NE in their serum mimic in vitro results of a pro-
inflammatory state 
 
   In Chapter 3, we found individuals with high levels of NE in their serum mimicked the 
changes we saw in vitro in memory CD8 T cells compared to the low NE level group. High levels 
of NE in the serum were associated with memory CD8 T cell increase in pro-inflammatory 
cytokines and a decrease in growth-related cytokines. Compared to our findings in vitro, these 
changes seen in the group with high levels of NE were influenced by multiple factors, aside from 
just NE. Still, it is impressive to find some inflammatory-related cytokines and chemokines in 
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adults with high levels of NE are also elevated in memory CD8 T cells compared to the low NE 
group, as we saw in vitro.  
As noted by previous literature, it is important to address the likelihood that changes seen 
in vivo could be the result of a combined influence of hormones and neurotransmitters, including 
NE, that directly or indirectly alter immune function (Straub et al., 2000;Straub et al., 1998). The 
bidirectional communication between the immune and nervous system may modulate the effects 
seen in vivo that were not seen in an in vitro investigation. In addition, immune cells are 
influenced by autocrine and paracrine factors in vivo that ultimately influence their function, 
kinetics, and cytokine production. It is difficult to separate the influence of neuroendocrine factors 
and immune cell functions in vivo. Further work needs to be done to better understand the role of 
NE in moderating CD8 T cell subsets’ function in vivo. Due to a laboratory error of mislabeled 
samples, we were unable to utilize all forty-one samples from our study, limiting sample size and 
hindering statistical significance. Unfortunately some of the NE samples were mislabeled by the 
laboratory staff, making it impossible to tell whether the sample belonged to a caregiver or non-
caregiver. We had to eliminate donors for the NE measurement analysis that had mislabeled NE 
measures for one or more time points. Larger investigations with humans need to be conducted 
to see if our observations could be repeated. 
Family caregivers of stem cell transplant patients have altered T cell function compared 
to matched controls 
 
 In Chapter 4 of this dissertation, we investigated differences between family caregivers of 
stem cell transplant patients and matched controls in terms of immunophenotype and CD8 T cell 
subsets (naïve and memory) expression of cytokines and intracellular cytokines. We did not find a 
significant difference in immune cell composition of caregivers compared to controls; however 
caregivers had increased expression of pro-inflammatory cytokines (TNF) and decreased 
expression of activation induced proliferative cytokines (IL2, IFNG). Intracellular level of TNF was 
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also increased at the protein level, though the other changes observed in gene expression were 
not seen in the intracellular cytokine measures.  
 Our findings concur with previous literature examining caregivers and matched control 
subjects to find caregivers’ illnesses last longer, they had lower levels of IL-2 from CD4 T cells as 
well as an increase in IL-6 production (Kiecolt-Glaser et al., 1987;Kiecolt-Glaser et al., 
1995;Kiecolt-Glaser et al., 2003). Another study found caregivers of Alzheimer’s patients had an 
altered immune composition with a 60% reduction in CD62L CD8 T cells (Mills et al., 1999); we 
did not see any significant change in immune composition in our caregiver population. In 
combination, these findings show that caregivers are at risk for a pro-inflammatory state which 
mimics that seen in aging (Gouin et al., 2008;Weng et al., 2012). Especially since these changes 
are seen in memory cells, caregivers may be at greater risk for opportunistic infections or 
infections with previously encountered antigens rather than new antigenic challenges that would 
be addressed by naïve cells. However, more work needs to be done with larger populations of 
caregivers and age- and gender-matched controls to verify these findings.  
Limitations 
 
 There were a few limitations to this work. One of the first challenges we faced was how 
we conceptualized chronic stress in an in vitro and in vivo setting; it is difficult to mimic a chronic 
stress environment in culture since in real life we can examine months or years of exposure to a 
stressor as a chronic experience. In culture, cell viability and limitations of cell survival limit our 
ability to induce a truly ‘chronic stress’ experience. While we attempted to induce a prolonged 
stress experience in our cells by treating them with norepinephrine for 16 hours, we were limited 
in the dosage and time of exposure to be able to see changes in the cells, but not cause 
extensive cell death by over treatment. Future studies like ours should identify the 
conceptualization of chronic stress and realize the limitations of conducting in vitro experiments. 
Other studies may benefit from a similar model of our work by studying stress-induced changes 
both in a culture and real life environment. 
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While we were able to detect transcriptional, translational and functional changes in CD8 
T cells after treatment with norepinephrine, we encountered challenges identifying the molecular 
changes, or epigenetic changes, behind these alterations in gene expression. Epigenetic 
methodology including chromatin immunoprecipitation assay (ChIP) requires significant amount 
of blood for isolation of CD8 T cell subsets to conduct the ChIP assay and is a challenging 
protocol in itself. Challenges with financial cost, protocol difficulty, adequate cell number and 
access to human donors limited our ability to conduct this experiment. Further work should be 
conducted in this area, though it is challenging to conduct, expensive and a time consuming 
process.   
 We were able to conduct a global gene expression analysis via microarray of central 
memory CD8 T cells and confirmation with RT-qPCR for the other CD8 T cell subsets (naïve and 
effector memory). While we would have liked to have done a microarray for the naïve and effector 
memory subsets as well, the cost of conducting a microarray and time-consuming nature of the 
assay and analysis prevented us from doing so. It may be worth in the future examining global 
gene expression changes in other immune cell subsets as well. 
 The study took place at the National Institutes of Health Clinical Center and Apheresis 
Unit at the National Institute on Aging, providing a diverse sample of participants. However, 
donors for the in vitro CD8 T cell work were a particularly healthy population, as selected for 
numerous studies at the NIH; thus, they may not be a representative sample of the general 
population, and particularly older adults since the NIA participants tend to be very healthy older 
adults. In addition, although we were able to detect statistical significance with our sample size for 
a few of the cytokines measured, we were limited in the number of donors from the caregiver and 
matched controls since this was a secondary study utilizing donors from a completed primary 
investigation at the NIH CC. We also were unable to salvage the majority of norepinephrine 
measures from these donors due to laboratory error, limiting our sample size further. In addition 
with our caregiver samples, we were only able to study our population by combining the blood 
samples from the pre- and post-transplantation collection time points in order to achieve 
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adequate cell number for experiments. It was impossible for us to get a baseline measure of 
individuals before they become caregivers; future studies may benefit from conducting 
longitudinal examinations of caregivers though this is a logistically challenging task. Still, 
longitudinal studies of individuals before, during and after they become family caregivers could 
provide valuable insight into the effects of chronic stress on immune outcome changes over time. 
Future Research 
 
 This dissertation adds to the preliminary literature about chronic stress effects via 
norepinephrine or caregiving on CD8 T cell subsets (naïve and memory) function in humans. 
There are a variety of avenues for future research resulting from the major findings of our studies, 
which are outlined below.  
Histone modifications and T cell alterations in chronically stressed populations 
 
 We have a very limited understanding of the mechanisms behind T cell alterations in 
chronically stressed populations. As discussed in Chapter 2, epigenetic modifications may serve 
as a mechanism and mediator of stress-induced changes in T cells, as well as other immune cell 
types. We cited previous studies that examined similar factors seen in family caregivers such as 
dietary alterations and traumatizing stress experiences that led to alterations in the epigenome 
and subsequent alterations in health outcomes. In order to understand if epigenetics plays a role 
in mediating the effects of chronic stress in family caregivers, studies must be completed with 
large populations of family caregivers and matched controls with isolated immune cell subsets, 
like CD8 T cells, to examine potential histone methylation markers and other epigenetic 
mechanisms that may moderate the pro-inflammatory response seen in this population.  
 Future research should also incorporate the large data analysis techniques that are now 
available. Technologies such as global gene expression analysis by microarray, as we conducted 
in Chapter 3, provide an opportunity to guide epigenetic work by knowing which genes are being 
over or under transcribed in individuals. The current methodologies for epigenetic studies require 
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a large number of cells, which poses a significant obstacle in obtaining a sufficient amount of 
blood from study participants. Technologies such as ChIP-Seq make it possible to analyze 
epigenetic modifications at a genome-wide level (Northrup et al., 2011;Sharov, Dudekula, and Ko, 
2005). While a significant amount of data will need to be analyzed by experts, these technologies 
can provide researchers insight into potential avenues to focus on in understanding stress-
induced alterations in immune function as mediated by epigenetic changes. 
Mechanisms behind stress induced changes in immune cells 
 
 Mechanisms behind altered immune responses can be direct by biological pathways or 
indirect, where stress leads to altered behaviors that in turn impacts immune responses. Our 
work focused primarily on the biological pathways that lead to immune dysfunction. To our 
knowledge, the examination of norepinephrine induced changes in gene expression, protein level 
and function in CD8 T cell subsets (naïve, central memory, effector memory) is the first of its kind. 
As described in detail in Chapter 2, we found memory CD8 T cells were more susceptible to the 
effects of norepinephrine than naïve cells due in part to their higher expression of the beta 2 
adrenergic receptor. We also found individuals with high serum levels of norepinephrine 
mimicked some of the changes we saw in culture with a pro-inflammatory state. We contributed 
to the literature in illustrating how norepinephrine, one of the important hormones released during 
a stress response, can mediate immune function.  
Other studies have examined how stress can lead to dysregulation of the immune 
response by studying the role of cortisol as a mediator between stress and vaccination 
responses. One study found an inverse relationship between cortisol levels and antibody 
responses to influenza vaccination in caregivers (Vedhara, Cox, Wilcock, Perks, Hunt, Anderson, 
Lightman, and Shanks, 1999), however they were unable to replicate this finding (Vedhara, Miles, 
Bennett, Plummer, Tallon, Brooks, Gale, Munnoch, Schreiber-Kounine, Fowler, Lightman, 
Sammon, Rayter, and Farndon, 2003). In another study children with the greatest cortisol 
increase had the lowest antibody responses to pneumococcal vaccination (Boyce, Adams, 
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Tschann, Cohen, Wara, and Gunnar, 1995). More studies with larger sample sizes need to be 
conducted to clarify if cortisol is a mechanism behind stress-induced altered immune function.  
 A few studies have focused on potential mediating mechanisms within the cell. For 
example, some focus has been on plasma and intracellular levels of cyclic AMP (cAMP) which is 
a low molecular weight substance that plays an important role in many control systems including 
acting as a second messenger after the binding of hormones to receptors on immune cells 
(Bonneau et al., 1990). cAMP has been shown to be able to inhibit lymphocyte proliferation, 
cytotoxicity, antibody production and cell migration. There have been studies on the increase of 
levels of cAMP in acute stress situations by beta adrenergic stimulation (Coffey and Hadden, 
1985;Okada, Tokumitsu, Honma, and Ui, 1991); however we do not know the impact of long term 
stress. In addition, more work needs to be done on the exact role of cyclic nucleotides, like cAMP, 
in modulating immune function. 
Coping moderates chronic stress-induced alterations in immune outcomes 
 
 Despite the reported poor health outcomes of family caregivers and other chronically 
stressed populations, there is little research on interventions to help moderate the stress-induced 
negative health alterations. For HSCT caregiver in particular, they are often most distressed at 
the time of transplant; thus, an intervention offering stress and coping skills may influence 
caregivers distress and improve their feelings of control (Laudenslager, 2014). Caregiver 
behavior is likely to benefit from interventions though the impact of coping interventions on 
processes like inflammation need to be elucidated (Laudenslager, 2014).  
 Furthermore, some caregivers may be ‘resilient’ or take on the responsibility of caregiving 
with less negative effects on their health compared to others; still, some caregivers are likely to 
require greater intervention since they may be a more vulnerable subset of caregivers compared 
to others (Brown, Smith, Schulz, Kabeto, Ubel, Poulin, Yi, Kim, and Langa, 2009;Kim, Schulz, 
and Carver, 2007). Further study needs to be done to examine different subsets of caregivers 
and the role of coping interventions on these groups. In addition, future work should examine the 
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effects of coping interventions for caregivers or the type of caregiver (vulnerable or resilient) on 
the patient’s health outcomes. The patient-caregiver dyad is an important relationship to examine, 
particularly in examining interventions to assist caregivers in better coping with their role (Bevans 
et al., 2011). One would assume a healthy and prepared caregiver would perform their duties 
better compared to a stressed caregiver; however this has rarely been examined in measurable 
physiological outcomes in caregivers or patients.   
 Notably, much of the work on caregivers have focused on their response to vaccination; 
many of these studies have been observational in nature and provided information on how 
stressed individuals respond to vaccination compared to non-stressed individuals (Glaser et al., 
1998;Gouin et al., 2008;Kiecolt-Glaser et al., 1996;Vedhara et al., 1999). A few studies examined 
the impact of coping interventions on vaccination including an emotional disclosure intervention 
on responses to Hepatitis B vaccination and found participants who completed the intervention 
had higher levels of Hepatitis B antibodies than controls 4 to 6 months later, though no immediate 
difference was seen post-vaccination (Pennebaker and Beall, 1986). In another study, caregivers 
of dementia patients underwent a stress-management intervention and found caregiver groups 
reported higher levels of distress before and after the intervention, however significantly more of 
the intervention caregivers generated a clinically appropriate response to the influenza vaccine 
compared to caregivers who did not undergo the intervention, and a fourfold increase in levels 
that exceeded the non-caregiver control group (Vedhara et al., 1999;Vedhara et al., 2003). 
Finally, a study examined the impact of a meditation intervention on influenza virus vaccination 
and found individuals who participated in the meditation had greater influenza virus antibodies in 
two follow-up periods compared to those who did not receive the intervention (Davidson, Kabat-
Zinn, Schumacher, Rosenkranz, Muller, Santorelli, Urbanowski, Harrington, Bonus, and Sheridan, 
2003). However more studies need to be done to determine the efficacy of these types of 
interventions since it has been suggested that the observed improvement in vaccination response 
may not be unique to the coping interventions (Smith, 2004). Still, these types of studies are 
106 
 
crucial since they can provide information that may aid in improving the effectiveness of 
vaccination programs, particularly for stressed populations.      
 
 Conclusion 
 In summary, this dissertation explored the impact of stress on gene expression, protein 
levels and function of CD8 T cell subsets by examining the effect of a stress released hormone, 
norepinephrine, and effect of caregiving of family caregivers of hematopoietic stem cell transplant 
recipients. We performed a review of the literature on epigenetic mechanisms as potential 
mediators of stress-induced changes in T cells, particularly in family caregivers, and discussed 
potential challenges and new technologies that are important for researchers conducting this type 
of research, as well as a proposed framework illustrating the role of epigenetic changes that had 
not been present in existing models of stress and caregiving and immune function. We 
discovered that not all immune cells respond similarly to the stress hormone, norepinephrine: 
memory CD8 T cells were more susceptible to the effects of norepinephrine and expressed more 
of the receptors for norepinephrine compared to naïve cells. We were the first to conduct a global 
gene expression analysis via microarray of norepinephrine treated cells and found norepinephrine 
induced a pro-inflammatory state before and after activation, as well as decreased expression of 
growth-related cytokines and chemokines after activation. We found individuals with high levels of 
norepinephrine in their serum mimicked the changes we saw in culture with an increase in pro-
inflammatory cytokines and chemokines. Finally, we found family caregivers of hematopoietic 
stem cell transplant recipients were prone to an increased pro-inflammatory cytokine production 
by memory CD8 T cells.  
 This dissertation builds on previous research examining the impact of stress on immune 
health with a specific focus on CD8 T cell subsets. Future research should explore how different 
subsets of immune cells may respond differently to stress or stress-related hormones, how 
different stress hormones impact immune cells, and the long term consequences of chronic 
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stress on immune health outcomes for a better understanding of how exposure to stress can 
modulate immune function in adults.  
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